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Peripheral nervous system (PNS) injuries affect many people worldwide and if not 
repaired can leave individuals with the burden of living with chronic pain or motor 
dysfunction.  My thesis focused on understanding the relationship nerves and neurons 
have with their environment during development and normal function in order to identify 
means by which the regenerative process might be manipulated and enhanced. The 
implementation of a two-armed study allowed me to investigate the interactions between 
Schwann cells (SCs), a vital neuronal support cell, and neurons, as well as, the role strain 
has in local protein synthesis. First, I detailed the changes in membrane stability within 
 
 
the two cell types. I was able to identify decreased velocity and correlative movement of 
neuronal membranes compared to SCs suggestive of a higher level of membrane stability. 
Both cell types saw a decreased trend in both velocity and correlative movement 
following development of contact with the other pointing to increased cellular membrane 
stability upon establishment of cellular contact. The next study looked into the 
development of ribosomal clusters within SC processes, which have been suggested to be 
a ribosomal source for axons following injury. I found that SCs develop ribosomal 
distributions early and use anterograde transport to maintain these populations. Upon the 
initiation of myelination, transport is depressed suggestive of a reduce role of ribosomes 
within the myelin fraction. The final portion of my work focused on neuronal adaptation 
to strain. I initially found that nerves are able to accommodate strains by straightening 
axons in a linear fashion. I further found moderate strain application to nerves 
upregulates the activation of both mTOR and S6, two molecules integral in enhancing 
protein synthesis. Additionally, increases in the cytoskeletal proteins β-actin and SMI31 
were observed in response to strain. Suppression of the mTOR pathway with rapamycin 
led to an elimination of the effect on SMI31 but not β-actin. Rapamycin also enabled a 
strain-dependent reduction in tubulin levels. The results of my thesis contextualize the 
results of a number of studies that have observed advantageous regenerative outcomes 
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Chapter 1: Introduction 
Section 1: The peripheral nervous system (PNS) 
The nervous system is composed of two major branches, the peripheral (PNS) and 
the central (CNS) (Figure 1-1). The CNS is composed of the brain and the spinal cord 
and generally tasked with integrating and processing signals it receives from the 
periphery. The PNS encompasses the remaining nerves which reside outside of the CNS.  
Normal, healthy function 
of the PNS is centrally 
important to the well-being and 
overall quality of life of all 
people. Tasked with both 
initiating movement through 
motor neurons and sensing 
one’s surroundings through 
sensory neurons, the PNS 
possesses a multitude of 
responsibilities. Any disruption to normal function, whether through traumatic injury or 
disease, can be crippling to an individual. 
Anatomically, the PNS is composed of both the autonomic and somatic nervous 
systems. The autonomic nervous system maintains necessary unconscious functioning 
including regulation of heart rate, breathing, and digestion. The somatic system, on the 
other hand, is responsible for voluntary muscle contractions and sensing a person’s 
surroundings. Both motor and sensory neurons possess cell bodies, or soma, located 
Figure 1-1: Nervous system [1] 
Diagram showing the two branches of the nervous 




adjacent to the spinal column in collections called ganglia. Motor neurons emerge 
ventrally within the ventral roots while sensory neurons project dorsally within the dorsal 
roots. From these positions neurons project long axons to their innervation sites. The 
axons descend distally from the spinal column in thicker bundles of axons resembling 
cables called neurons. In this manner axons can extend to lengths of up to one meter in 
the extremities of humans. 
Section 2: Peripheral Nervous System Injury and Statistics 
Traumatic PNS injuries, the partial or complete severance of a nerve, frequently 
result from automobile accidents, violence, and military conflict [7,8]. Up to 1% of 
individuals by the age of 70 can expect to experience some type of traumatic peripheral 
nerve injury costing individuals and private businesses billions of dollars in care and lost 
wages [9]. In addition to financial cost, there is also a substantial cost to quality of life, 
including an inability to perform basic daily activities and considerable loss of 
independence resulting from disrupted motor function and chronic pain [8]. Patients 
presenting with a peripheral nerve injury will often receive surgical intervention 
following reduction of inflammation at the site of injury followed by physical therapy in 
an attempt to restore function. Nonetheless, over 30% of patients still report poor or no 
functional recovery following injury [10]. 
Section 3: Current Therapeutic Techniques 
Currently the prognosis of a particular injury directly relates to the size of the 
trauma. Best outcomes are expected if the surgeon is able to directly reattach the severed 
ends together. In many cases tissue may be lost or damaged to the point that it must be 
cleaned up prior to reattachment to permit regrowth of healthy tissue. The gap that exists 
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or develops during the surgical procedure explicitly correlates to the patient’s prognosis 
[11,12]. 
Due to the presence of a gap, axonal regrowth must be directed into the distal 
portion of the severed nerve. For larger gaps this is often accomplished by the use of 
nerve tissue, either from the patient (autograft), a donor (allograft), or another species 
(xenograft). Current allograft options have been successful at bridging gaps up to 50 mm 
in length [13]. For smaller gap sizes tissue engineered nerve guidance conduits have been 
moderately successful. Tissue engineered solutions offer many benefits above native 
tissue including the absence of donor site morbidity and the availability of materials. 
Nonetheless, they are only consistently used clinically to bridge gaps of less than 30 mm 
[14]. When the expected outcomes of these devices reach those of the autograft they will 
offer a viable alternative for doctors performing nerve repair procedures. 
Numerous efforts are being made to explore methods to enhance the effectiveness 
of tissue engineered conduits by attempting to accelerate the axonal elongation rate. 
Prolonged denervation of the target muscle leads to atrophy and negatively affects 
recovery prognosis [15].  Tissue engineers are examining a number of areas that affect 
axonal outgrowth including growth factors [16], physical guidance cues [17], material 
compatibility [18,19], introduction of support cells [20], and application of strain [21] 
among others as potential means of intervention.  
Section 4: Thesis scope 
In my thesis I investigated two means by which scientists believe recovery could 
be accelerated. First, I focused on the interplay between neurons and Schwann cells and 
the way by which Schwann cells may affect the recovery process (Chapters 2 and 3). This 
was followed by an investigation into the role strain plays on enhancing constructive 
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local signaling pathways and local protein synthesis (Chapters 4 and 5). In these two 
distinct arms of my dissertation work I was able to explore multiple modalities by which 
the regeneration process could be affected and accelerated. 
Section 5: Developmental and regenerative role of Schwann cells 
The PNS is composed of a number of different cell types. While neurons are the 
most notable cell type, their support cells, particularly Schwann cells, play an integral 
role in axonal health and viability. Schwann cells are most noted for enhancing neuronal 
conduction velocities through the process of myelination [22]. In addition to this major 
role, Schwann cells aid neurons through additional mechanisms including provision of 
physical guidance cues [23] and growth factors [24-26] to promote axonal elongation 
during development and regeneration. Additionally, recent evidence shows Schwann 
cells act as an additional source of axonal ribosomes for local protein synthesis during the 
regeneration process [27,28]. 
Subsection 1: Stabilization/axon guidance during development/following injury 
During development Schwann cells receive signals promoting migration along 
axons to position themselves for myelination [29-33]. During the regeneration process the 
roles reverse with Schwann cells forming a substrate promoting axonal extension and 
guides neuronal regrowth [23]. In both cases, physical interactions between the two cell 
types are able to provide specific cues to direct proper functional development or 
recovery. Many examples of contact driven effects between Schwann cells and neurons 
exist illustrating how the two cell types generally stabilize each other. Specifically, 
Schwann cells upregulate adhesion levels [34] following contact with neurons. On the 
other hand, contact between Schwann cells and neurons can lead to enhancement of 
neurofilament phosphorylation, indicative of a more stable cytoskeleton [35].   
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Interestingly, membrane addition and retrieval in neurons primarily occurs at the 
growth cone and cell body and “flows” along the axon [36-42]. In contrast, other 
migratory cells do not observe this membrane flow [43]. Additionally, in neurons, 
membrane addition is coupled to the cytoskeletal stability and regional tension within the 
membrane [44-47]. Such concepts of membrane flow and cytoskeletal stability have not 
been tested in developing Schwann cells, but would provide insight into the role of 
cytoskeletal stabilization on membrane stability during their dynamic development. 
To gain such insight, I performed a comparative assessment of the influence 
contact has on the membrane stability of both Schwann cells and neurons in Chapter 2.  I 
found that neurons possess more stable membranes compared to Schwann cells, as 
evidenced by reductions in both membrane velocities and membrane continuity. These 
parameters exhibited a decreasing trend upon the establishment of contact with each other 
suggesting a role for contact in stabilizing the two cell types. The work resulted in a first-
author publication in Cellular and Molecular Bioengineering (reprinted with permission 
from Springer) [2]. 
Subsection 2: Myelination, material transfer, growth factor influences, ribosomal 
transfer 
Recent evidence has shown another way Schwann cells aid neurons is by 
transferring ribosomes to neurons following injury [27,28]. These studies fail to identify 
mechanistically how this occurs but hypothesize that the transfer events may occur at 
Schmidt-Lanterman incisures (Figure 1-2) [27]. In order for this to occur, ribosomes must 
localize to Schwann cell projections during development and to the myelin following 
compaction. A niche of literature has identified roles for projection and myelin based 
ribosomes mainly focusing on the role of these structures to provide myelin basic protein 
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(MBP) during compaction [48-52]. Within these studies it is noted that ribosomes 
localize around, but not within, Schmidt-Lanterman incisures [48]. Missing from the 
current literature is a full understanding of how ribosomes are distributed within the 
Schwann cell and how they achieve this distribution over time.  
My exploration of ribosomal distributions and the rates of ribosomal transport 
over early developmental time points following induction of myelination are discussed at 
length in Chapter 3. The goal for this study was to identify how ribosome trafficking and 
distributions change throughout development. Specifically, I looked to identify whether 
ribosomal populations remained within the early myelinating projections and whether 
these distributions were found to co-localize to particular cytoskeletal elements. I also 
wanted to determine if these ribosomal populations were maintained through anterograde 
trafficking to support the idea that populations are maintained and residing in the myelin 
fraction in the event Schwann cells are signaled to transfer ribosomes to the neurons they 
myelinate. I found that distributions are established along the Schwann established and 
maintained from early time points in culture. The net amount of ribosomal trafficking 
decreased as a result of myelination induction suggesting a decreased role for local 
synthesis within the myelin compartment. This work resulted in the submission of a first-
author manuscript. 
Section 6: Role of Strain 
Another means being investigated for enhancement of PNS regeneration is the 
effect of strain application on neuronal outgrowth. Current surgical best practice is to 
leave nerves in a tensionless environment following nerve repair. However, evidence is 
building both in vitro and in vivo that application of strain can be beneficial for axonal 
outgrowth, accelerating the rate of axonal elongation. 
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Figure 1-2: Myelinating Schwann cell [53] 
Myelinating Schwann cells possess a number of distinct regions important in maintaining 
proper function. Schmidt-Lanterman incisures (SLI) are regions of direct membrane-
membrane contact between Schwann cells and neurons. (Reprinted with permission from 
Nature Publishing Group) 
 
Subsection 1: Neuronal architecture 
Nerves in vivo are subject to fairly large deformations with minimal damage [54]. 
Studies have shown that deformations exceeding the physiological range negatively 
affect neuronal function as noted by conduction velocity and magnitude deficits [55,56]. 
This damage can be fully reversible for low level strains but is only minimally reversible 
for larger strains [55,56]. Nerves are able to accommodate physiological deformation due 
to a unique packing structure that imparts a native waviness on the axons within the nerve 
bundle [57]. In this way, the nerves are able to undergo large strains while being 
subjected to very low levels of stress [55]. As the nerve is strained the axons unravel 
imparting minimal strain on the axons themselves [58]. The microscopic packing 
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structure contributes to the macroscopic observation of bands of Fontana (Figure 1-3) 
[58]. These bands are apparent to the naked eye and respond to strain by elongating [3]. 
Due to the repeating nature of the bands, I looked to correlate the frequency of the bands 
with imposed strain using a Fourier analysis based method in Chapter 4 [3]. Development 
of this method would provide further evidence that the effect results from deformation of 
underlying physical structures, as elongating the physical specimen would decrease the 
observed frequency. Implementation of this technique could provide surgeons with an 
effective tool in the operating room for estimating accidental and intentional strains 
applied to nerves during surgery. In Chapter 4, I discuss how this technique found 
correlations between applied strain and banding frequency, as well as, agreement 
between the strain at which damage occurs (>20%) and the point when the bands 
ultimately are no longer visible. This work resulted in a first-author publication in Muscle 
& Nerve (permission requested for republication from John Wiley and Sons, Inc.) [3]. 
 
Figure 1-3: Bands of Fontana [3] 
 
Subsection 2: Local protein synthesis 
This geometry of neurons is a major confounding factor of axonal regeneration. 
The localization of neuronal cell bodies up to one meter away from the injury site in the 
most distal cases leads to a temporal delay in response to an injury stimulus. This delay 
affects both transcriptional and translational regulation at the cell body. The manufacture 
and shipment of proteins from the cell body to the injury site would, in the case of slow 
axonal transport (around 1 mm/day) [59,60], likely take months. In order to regenerate in 
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a timelier manner, the axon has the ability to locally produce proteins within the axonal 
compartment [61,62], as well as, the ability to respond to cues from the local cellular 
environment [63].  
In the past twenty years, the observation of protein synthetic machinery including 
ribosomes, golgi, and ER components present in the axon has provided evidence for local 
synthesis of proteins [62,64]. The observation of specific mRNAs localized to the axonal 
compartment has offered further insight into the roles of local synthesis (Figure 1-4) 
[62,65]. Of these mRNAs, a number are cytoskeletal in nature including β-actin, all 
neurofilaments, and tubulin [66-68]. Additionally, evidence shows that axonal extension 
and regeneration is dependent on the ability of a neuron to produce proteins within the 
axon [69]. Other studies have shown that restoration of this process can lead to recovery 
of the axons ability to regenerate [70]. A combined look at this evidence provides support 
for the integral nature and therapeutic potential of this pathway with regards to neuronal 
regeneration. 
 
Figure 1-4 - Axonal protein synthesis 
Neurons possess ribosomes in both the cell body and the axonal compartment. Both pools 
of ribosomes are integral in maintaining the well-being of the cell. 
 
Subsection 3: Strain and axonal elongation 
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Since nerves are generally considered to be non-load bearing, the influence of 
mechanical strains on their growth potential was initially ignored. This generalization 
fails to consider the fact that neurons innervate muscles early in development and must 
grow over the life of an individual. Additionally, the positive outcomes seen in limb 
lengthening surgeries provide evidence for neuronal adaptability to applied strains [71]. 
In load bearing tissues including muscle, bone, and cartilage there is a wealth of evidence 
showing the influence of mechanical loading in affecting tissue adaptations (reviewed in 
[72-74]). This work shows, in most cases, physiological loading conditions can positively 
influence the development of these tissues. The subset of literature focusing on neuronal 
tissues appears to be closing in on a similar trend. In vitro evidence has shown that strain 
application can accelerate the process of axonal elongation up to eight-fold when applied 
at initially low strain rates are slowly increased [75-77]. More complex experiments are 
being completed in vivo. While the verdict is still out at this point, they do not seem to be 
negatively affecting neuronal regeneration [21,78]. This initial work has opened a 
number of questions related to the process of neuronal adaptation to strain, most notably 
the mechanism which allows for accelerated elongation.  
Subsection 4: Strain-mediated signaling 
While it is unclear how neurons adapt to strain application, the activated signaling 
pathways in other systems are very well-documented. In muscles it has been determined 
that mTOR activation during cyclic loading is responsible for observed increases in 
protein synthesis and hypertrophy [79,80] (pathway in Figure 1-5). The well-established 
role for mTOR signaling in axonal elongation and axonal protein synthesis makes this 
pathway particularly attractive for implication in the beneficial response of neurons to 
strain application. Axonal protein synthesis is required for axonal extension and 
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regeneration. Evidence also suggests that not only is mTOR activity necessary for axonal 
outgrowth [81,82] but enhancement of the mTOR signal via pTEN inhibition can 
enhance the outgrowth capacity [70]. A number of axonally synthesized proteins could be 
beneficial for axonal growth including the cytoskeletal proteins β-actin, neurofilament-H, 
and tubulin [66-68] Enrichment of the pools of these essential structural proteins could be 
responsible for the observed increase in axonal elongation rates. In Chapter 5 I 
investigated the role of mTOR signaling in response to locally applied strains in vivo and 
the affect this had on local cytoskeletal protein levels.  This work builds upon the in vitro 
studies detailing I found that both mTOR and downstream S6 activation levels increase in 
whole nerve following the application of strain. Additionally, increased levels of β-actin 
and phosphorylated neurofilament-H (SMI31) were observed. In the presence of 
rapamycin, an inhibitor of mTOR activity, I found differential regulation of cytoskeletal 
elements in response to strain including a muting of the SMI31 response, as well as, a 
decrease in the levels of tubulin. While my work pertains to a protein synthetic 
requirement for axonal elongation, it is important to note that additional contributions in 
the form of lipid and energetic requirements must be considered to place this work in the 
context of whole cell growth and survival. This work is currently in preparation for 
submission of a first-author manuscript to a peer-reviewed journal. 
Section 7: Intersection of research aims 
The two-armed approach to my dissertation work has allowed me to explore 
diverse aspects of the nervous system each of which could prove critical to the 
regeneration process. While Chapters 2 and 3 focus on Schwann cell and neuron 
interactions in the context of development and potential regenerative application, 
Chapters 4 and 5 looked into the ability of nerves and neurons to positively respond to 
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strain. Nonetheless, the information obtained from each of these subsets provides initial 
evidence to tailor future research towards integrating approaches for optimal regeneration 
following peripheral nervous system injuries. Direct implications of both may be seen in 
the enhancement of axonal protein synthesis, a major requirement of the neuronal 
recovery process. On a broader scale, development of more effective regeneration 
strategies will allow individuals currently destined to live with chronic pain and reduced 
motor function to live lives not affected by these complications while reducing the 
financial burden on society as a whole. These advancements will reduce the burden on 
the individual in performing activities of daily living enabling easier living and a more 
positive outlook. My work comprises a small segment of the wealth of research that has 
been done and must continue in order to reach the point where surgeons can offer 
universal restoration of function to all individuals suffering from PNS injuries and 
diseases. 
 
Figure 1-5: mTOR 
signaling pathway [83] 
Diagram outlining 
important elements in the 
mTOR driven protein 
synthesis pathway 
(Reprinted with 





Chapter 2: Variability in membrane continuity between Schwann 
cells and neurons [2] 
Section 1: Introduction 
Sensory neurons of the dorsal root ganglia (DRG) and Schwann cells (SCs), two 
distinct cell types of the peripheral nervous system (PNS), cooperate to provide 
functional signaling between the spinal cord of the central nervous system (CNS) and the 
distal reaches of the human body. The health, well-being, and proper performance of the 
two cell types integrally depend on those of the other. Both neurons and SCs possess a 
distinctive bipolar morphology that results in a high surface area to volume ratio. 
Maintenance of this morphology requires careful regulation of the expansion and 
contraction of the cellular plasma membrane as well as its interactions with structural 
elements in adhesion complexes and the intracellular cytoskeleton. Such regulation is 
particularly critical during cell movement or the extension and retraction of cellular 
projections.  
There are multiple common principles underlying the motility of neurons and 
SCs. In the context of neuronal outgrowth, several studies have demonstrated the 
essential role of the cytoskeleton in growth cone motility, axonal guidance, and axonal 
transport [84-86]. More recently, studies have also focused on the regulation of the 
biomechanical properties of the axonal shaft during its outgrowth. This may occur 
through the generation of tensile forces along the axon and at the growth cone [87-89] as 
well as reorganization of the cytoskeleton and adhesion complexes in response to stresses 
and mechanotransductive signals [90-92]. Mechanisms guiding the addition of cellular 
membrane have also been examined in neurons, particularly during axonal outgrowth. 
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The growth cone is the most frequent site of membrane addition and retrieval, though a 
significant component may be added along the axon or flow anterogradely from cell 
bodies [36-42]. Membrane addition and retrieval are tightly coupled to the stability of 
actin and microtubule components of the cytoskeleton [44,45] as well as adhesion and 
regional tension within of the cell membrane [41,46,47]. This contrasts greatly with 
migratory cell types like keratocytes which do not witness any lipid flow [43]. Key 
influences on lipid flow as well as its quantification are therefore likely to include the 
nature of membrane connectivity to the cytoskeleton as well as regional differences in 
membrane composition. 
Fewer studies have investigated force generation, cytoskeletal stability, and 
membrane dynamics in the projections of SCs, despite the importance of these processes 
during their migratory phase prior to myelination [93]. Studies of SC movement along 
fibrous scaffolds suggest that they, like neurons, follow mechanical guidance cues and 
can generate traction forces sufficient to break attachments at the trailing end [94-97]. 
Magnitudes and orientations of these forces have not been examined in SCs, though they 
may be analogous to other migratory cell types such as fibroblasts [98]. As for neurons, 
there is evidence that their microtubule stability plays a role in the plasma membrane 
expansion in SCs [99]. In addition, it has been shown that dynamics of cellular adhesion 
and actin networks play critical roles in SC spreading and migration [34,100]. 
Despite these conceptual similarities between neurons and SCs, we hypothesize 
that regional differences in the continuity of the plasma membrane may contribute to 
differences in physiological function required for the two cell types to operate in a 
mutualistic fashion. This study investigated differences in the mobility of the plasma 
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membrane in neurons and SCs, and compared the degree to which and length scale over 
which the cellular membranes of neurons and SCs behave as a mechanical continuum. In 
combination with high-resolution fluorescence imaging, we applied two different 
methods for correlation analysis previously used in other contexts [86,101,102] to 
quantify the continuity of the cellular membrane at various length scales during neuronal 
and SC motility. The establishment of neuronal contact was investigated as an additional 
factor influencing continuity; for neurons, such contact indicates a major step in maturity 
prior to axonal fasciculation, and for SCs, neuronal contact is required both for 
elongation along an axon and myelination [34,103-107] We propose that cells with more 
mobile tendencies, like SC migration, may have membranes that act more like a 
continuum, enabling more efficient mechanical communication. 
Section 2: Materials and Methods 
Subsection 1: Cell culture 
Day 1-5 Sprague-Dawley rats were euthanized using CO2 followed by 
decapitation. All animal protocols were approved and carried out in accordance with 
IACUC at the University of Maryland, College Park and University of California, San 
Diego. DRGs were dissected and placed on ice in 400 µl of DRG media (F-12 media, 
10% FBS, 1% L-glutamate, and 1% Penicillin/Streptomycin). The samples were 
supplemented with 20 µg/ml of collagenase type IA (Sigma-Aldrich) and incubated at 
37°C for 20 minutes (adapted from Oh et al.) [101,108]. The samples were then 
centrifuged at 76xg for 5 minutes and the media was removed. The DRGs were 
resuspended and dissociated in fresh DRG media.  
Schwann cells were harvested from DRGs (with neurons) or sciatic nerves (no 
neurons). For the latter, cells were digested; first, in 3.33 mg/mL collagenase in L-15 for 
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45 minutes followed by digestion in 3 mL of 0.25% trypsin-EDTA and 1 mL of 1.2 
mg/mL DNase I in L-15. The cells were suspended and cultured in Schwann cell media 
(DMEM containing 10% FBS, 1% Pennicillin/Streptomycin, .02 g/mL, and .1 mg/mL 
Pituitary Extract) (Adapted through correspondence with Megan Wright from original 
protocol of Porter et al.) [109]. Cells were dispersed on 35 mm glass-bottom culture 
dishes coated in 8 µg/ml laminin (Sigma-Aldrich) for future viewing at a density of ~4 
DRGs per plate and supplemented with 2 ml of DRG media. The cells were cultured 
overnight at 37°C prior to experimentation. 
For cultures of isolated neurons, following resuspension in DRG media, the cells 
were again centrifuged at 76xg for 5 minutes. Media was removed and the cells were 
resuspended in 100 µl Basic Rat Nucleofector solution (Amaxa). Cells were 
electroporated using Amaxa Nucleofector technology and program G-013 to minimize 
contaminating fibroblasts and SCs. Cells were placed in RPMI and incubated for 15 
minutes prior to plating to facilitate recovery. Post-recovery, cells were placed on glass-
bottom dishes and confined to a region ~10 mm in diameter at a density of ~4 DRGs per 
plate and supplemented with 500 µl of DRG media containing 10 µg/ml NGF 7-S 
(Sigma-Aldrich) and 2% B-27 (Sigma-Aldrich). The cells were cultured overnight at 
37°C prior to experimentation. 
Subsection 2: Experimental Groups 
Four experimental groups were identified based upon cell type and contact state. 
These groups were contacting neurons (NC), non-contacting neurons (NNC), contacting 
Schwann cells (SCC), and non-contacting Schwann cells (SCNC). Contact was defined 
based on the contact of the distal tip of a neuronal growth cone or a Schwann cell 
projection with a neuron. Cell types were identified by morphology following initial 
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identification by immunostaining for S100 (Figure 2-1B) to identify SCs and the 
neurofilament SMI-31 (Figure 2-1D) to identify neurons. 
 
Figure 2-1: Identification of cell types and verification of imaging methods 
Identification of Schwann cell imaged under DIC (A) confirmed by S100 
immunostaining (B) and DRG imaged under DIC (C) confirmed by SMI31 
immunostaining (D). Both Schwann cells (E,F,G) and DRGs (H,I,J) identified under DIC 
(E,H) were examined for internalization of wheat-germ agglutinin (F,I) identified by 
incubation with fluorescent dextran (G,J) with minimal internalization occurring at the 





Subsection 3: Labeling of plasma membrane surface 
Wheat germ agglutinin was used as a label for plasma membrane, as it has 
multiple binding sites for extracellular membrane bound sugars such as sialic acid and N-
acetylglucosaminyl [110]. Wheat germ agglutinin conjugated to Oregon Green 488 
(Invitrogen) was added to cultures at a concentration of 1.67 µg/ml, a concentration four-
fold lower than that recommendation by the reagent literature. The cultures were then 
placed at 2°C for 10 minutes to allow binding and limit initial endocytosis. Imaging was 
performed immediately afterwards; as a positive control for endocytosis, cultures were 
examined after 4 hours (Supplemental Figure 2-1C). Minimization of endocytosis during 
refrigeration was confirmed through co-labeling with dextran conjugated to Alexa Fluor 
594 (Invitrogen) added prior to refrigeration at a concentration of 5 mg/ml (Figures 2-1G 
and 2-1J). Minimal dextran internalization was observed at the cell body and growth cone 
and virtually absent along the projection/axon providing evidence that the majority, 
although perhaps not all, of the observed particles externally labeled the membrane. 
Following refrigeration, the plates were washed three times with cold PBS, media was 
replaced with cold DRG media and the cultures were imaged. An additional control was 
performed, imaging the WGA using confocal techniques (Supplemental Figure 2-1E). 
Subsection 4: Imaging 
Using an inverted TE-2000E microscope (Nikon) with a Lumen PRO2000 
illumination system (Prior Scientific), CoolSNAP HQ2 (Photometrics), and Chroma 
filters (Bellows Falls,VT. EPI: 490 nm (FITC), 595 (Texas Red); Emission 525 nm 
(FITC), 620 nm (Texas Red)), both fluorescent (492 nm, 594 nm) and DIC images were 
gathered every 20 seconds for a period of 20 minutes to allow characterization of 
membrane mobility over time. This relatively infrequent imaging rate of fluorescence 
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combined with the low concentration of WGA dye reduced the likelihood of photoxicity, 
which otherwise manifest itself through axonal beading (Supplemental Figure 2-1B) or 
axonal retraction. Failure to see axonal elongation likely resulted from refrigeration prior 
to imaging slowing the rate of cellular processes.  It should be noted that an elongation 
rate of ~30 μm/hr is seen following a four hour recovery at 37°C suggesting no 
permanent damage has been inflicted by refrigeration. An optimal environment was 
maintained at 37°C with ~4% CO2 through a custom environmental chamber mounted 
around the microscope stage (Precision Plastics). For still fluorescent images of 
immunostains, this imaging system was also used without environmental considerations.  
For direct examination of endocytosis, confocal microscopy was used. Cells were imaged 
using a Leica SP5 system. Standard lasers and filters were used. An argon laser enabled 
excitation at 488nm and emission was captured between 500-550 nm.  
Subsection 5: Image Processing 
The image sequences gathered from each sample were analyzed using custom 
MATLAB programs (Mathworks Inc.). In each image, the cellular projection was traced.  
A region of 9 pixels surrounding the trace (trace ± 4 pixels) was cropped and organized in 
order beginning with the first time point at the top and following with the second below 
it, etc. This organization represents time in y-direction and position along the cell in the 
x-direction much like a traditional kymograph and as such we will refer to our analysis 
technique as a kymograph as well (Figures 2-2C and 2-2F). The paths of particles that 





Figure 2-2: Methods of experimental analysis 
Time lapsed images of the Schwann cells (A) and neurons (D) were taken under DIC and 
fluorescence to identify localization of fluorescent wheat-germ agglutinin (B, Schwann 
cells; E, neurons). Traces of the cellular projections at each time point were composed 
into a kymograph (C, Schwann cells; F, neurons) with tracks of wheat-germ densities 
being identified. Correlation of these tracks was identified using two methods of analysis: 
cross-correlation (G) and regression (H). Vertical arrows throughout figure represent 




Subsection 6: Analysis 
Analysis was performed using MATLAB and all programs are available upon 
request. For analysis of correlation, particles were correlated by plotting the x-value 
corresponding to the position of one particle at a given time against the x-value 
corresponding to another particle at the same time [86,101]. This was done for all time 
points. It is important to note that this differs from conventional analysis of correlation 
and provides different measurements than traditional correlation length due to temporal 
and spatial resolutions and scope of our imaging techniques [111]. Traditional techniques 
are typically applied to individual lipid diffusion characteristics. The plot was fit using a 
linear regression and correlation was determined based upon the R
2
 value of the fit. A 
high R
2
 value represents two particles that move consistently in the same direction, 
although the magnitude of these displacements may not necessarily be the same (Figure 
2-2H). An R
2
 value of 0.9 or above was considered to represent strong correlation 
although the data appeared to be continuous and independent of the cut-off selection. 
Comparisons were made amongst all tracks in each video if the two tracks co-existed for 
over 1 minute. Lesser times were ignored due to inflated correlation among small data 
sets.  
A second method, performed in MATLAB, utilized cross correlation analysis 
amongst tracks within a video and sequential frame shifts of the data to identify 
correlation regardless of slight temporal shifts in movement propagation. The sequences 
were normalized such that the autocorrelations at zero were equal to 1. The maximum 
correlation was then identified for each correlogram and a maximum value greater than 
0.9 was used as a threshold for strong correlation between particles (Figure 2-2G). The 
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percentage of correlated particles in each sample (by either regression or cross 
correlation) was compared across cell type and across contact state.  
To elucidate the role of regional velocity in the continuity of the membrane, the 
average velocity of all particles within a given sample was calculated by averaging the 
mean velocity of individual particles in the given sample. Also identified was the 
percentage of stationary tracks, defined based on a displacement less than that of a 
particle moving constantly at a velocity of 0.6 m/min for the entirety of the movie.  
Statistical analysis was performed in Microsoft Excel (Microsoft) and SAS (SAS Institute 
Inc.). Means were compared using 1-way or 2-way ANOVA followed by Tukey’s post 
hoc tests, and distributions were compared using Kolmogorov-Smirnov tests. 
Subsection 7: Immunostaining 
Samples were fixed in 4% paraformalin for 10 minutes. Following fixation, 
samples were washed three times with PBS followed by permeabilization with 0.2 % 
Triton-X 100 in PBS for 5 minutes. Again samples were washed three times with PBS 
and placed in blocking solution consisting of 10 % FBS in PBS for 25 minutes at room 
temperature. Post-blocking, the samples were washed three times with PBS. Primary 
monoclonal antibodies targeting talin (Sigma-Aldrich T3287), S100 (Sigma-Aldrich 
S2532) and SMI-31 (abcam ab24573) were diluted in blocking solution (1:750, 1:200, 
and 1:1000, respectively) and samples were incubated in the primary antibody for one 
and a half hours at room temperature. Following primary incubation, the samples were 
washed three times with PBS and placed for 2 hours in either Alexa Fluor 488-goat anti-
mouse (Invitrogen A-11001) or Alexa Fluor 594-goat anti-mouse (Invitrogen A-11032) 
that had been diluted (1:200) in blocking buffer. The sample was washed three times with 
PBS, left in PBS and imaged. ImageJ (NIH) was used to determine fluorescence levels 
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for analysis performed Excel (Microsoft). A threshold level of 440 LUTs was chosen 
after identifying highly fluorescent patches on cells to have these mean values. 
Section 3: Results 
Subsection 1: Identification of Neurons and Schwann cells and labeling of plasma 
membrane 
Schwann cells (Figures 2-1A and 2-1B) were initially identified by antibody 
labeling against S-100 as has been used previously [112]. Additionally, neurons (Figures 
2-1C and 2-1D) were identified by antibody labeling against SMI-31, for identification of 
phosphorylated axonal neurofilaments. Subsequent live-cell imaging experiments relied 
on identification of SCs by their thicker projections (~3-4 m) relative to neurons, bipolar 
morphology, and elliptical cell body (Figures 2-1A, 2-1C, 2-1E, and 2-1H). Neurons 
were identified based on observation of thin projections (~1 m) and more rounded cell 
bodies. 
Plasma membrane was labeled with wheat-germ agglutinin conjugated to Oregon 
Green 488. Fluorescent densities were observed along the projections of both cell types 
and allowed characterization of membrane dynamics in real time (Figures 2-1F and 2-1I). 
Neurons appeared healthy as evidenced by growth cone ruffling (Supplemental Figure 2-
1A). In the rare case photodamage was witnessed by axonal blebbing, these samples were 
ignored (Supplemental Figure 2-1B). Due to incubation at 2C endocytosis was 
minimized as evidenced by minimal uptake of fluorescently labeled dextran (Figures 2-
1G and 2-1J). In SCs, slight uptake was observed at the cell body and lamellipodia. 
Additionally, fast rates of transport, indicative of WGA uptake and vesicular transport, 
were not observed following incubation at 2C compared to a 4 hr incubation period at 
37C (Supplemental Figure 2-1C). Confocal imaging also revealed restriction of WGA to 
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the cellular surface and its absence within the cytoplasm of the cell (Supplemental Figure 
2-1D). 
Subsection 2: Membrane correlation and velocity in SCs and neurons 
We generated kymographs (Figures 2-2A-F) to track the movement of particles 
throughout the duration of each experiment. We used two methods to identify the degree 
of correlation of particles with each other in each cell type (Figures 2-2G and 2-2H). 
Using cross-correlation analysis of all particles along a neuronal projection (Figure 2-
2G), the percentage of correlated pairs with a maximum correlation value of over 0.9 was 
found to be 24.51%. This percentage rose significantly (p<0.0145, t-test) to 42.37% in 
SCs (Figure 2-3A). Similarly, the percentage of correlated pairs based on regression 
analysis (Figure 2-2H) and a minimum R
2
 of 0.9 in all neurons was 7.07%. This 
percentage rose, though not significantly (p<0.0757, t-test) to 14.87% in all SCs (Figure 
2-3B).  
The length scale at which correlation occurs also depended upon cell type, and 
varied slightly depending on the method used to classify correlation. Using cross-
correlation analysis, the median distance between correlated particles was found to be 
39.05 m for neurons and 35.86 m for SCs (Figure 2-3C). This reduction in length scale 
in the correlated particles of SCs was not significantly different (p=0.0814, Kolmogorov-
Smirnov). Similar analysis was performed using regression analysis; the median distance 
was 46.27 m for neurons and 16.70 m for SCs (Figure 2-3D). Distributions here were 






Figure 2-3: Membrane correlation and velocity by cell type 
Percentage of correlated WGA pairs by cross-correlation (A) and regression analysis (B) 
*p < 0.015 (v. neurons, t-test). Values represent means  SEM (n = 15). Cumulative 
histogram of the distance between correlated particles within given pairs for both cross-
correlation (C) and regression analysis (D) *p < 0.0001 (v. neurons, Kolmogorov-
Smirnov test). Average velocities of WGA particles (E) *p < 0.05 (v. neurons, t-test). 
Values represent means  SEM (n = 15). Cumulative histogram of individual positive (F) 
and negative (G) velocities *p < 0.0001 (v. neurons, Kolmogorov-Smirnov test).  
 
longer-range correlation throughout neuronal membranes and continuity over a shorter 
length scale in SCs. These metrics should not be confused with traditional correlation 
lengths of lipids; rather they simply refer to the distances between particles observed to 
possess correlated movement patterns. Both cross-correlation and regression analysis 
presented consistent trends in correlation in these initial comparisons; subsequent 
analysis was performed utilizing only cross-correlation analysis. 
The velocity of particles on the membrane, corresponding to regions of the 
membrane, was identified to test whether physical mobility may affect or be affected by 
membrane correlation. The average velocity of neuronal membrane particles was found 
to be 0.052 m/min with those of SCs averaging -0.165 m/min (Figure 2-3E). 
Significance was identified for the two experimental populations (p = 0.0469, t-test). The 
average positive velocities also differed significantly (0.351 m/min, neurons; 0.662 
m/min, Schwann cells; p = 0.0062, t-test), as did the average negative velocities (-0.319 
m/min, neurons; 0.843 m/min, Schwann cells; p = 0.003, t-test). It is of note that the 
movement witnessed in Schwann cells was observed throughout the projection. Neuronal 
particles from the study possessed a reduced average positive velocity compared to those 
incubated at 37°C for 4 hours (Supplemental Figure 2-1D), characterized by the 
rightward shift in the graph and increase in half-max value (0.283 m/min, no incubation; 
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0.459 m/min, 4-hour incubation; p<0.0001, K-S). The particles observed after 4 hours 
thus likely contain an additional sub-population of mobile, presumably internalized 
particles in addition to less mobile particles seen under both incubation conditions.  
Subsection 3: Membrane correlation and velocity in SCs and neurons by contact 
state 
To test whether differences in membrane correlation between SCs and neurons 
were influenced by their contact with another neuron, we utilized cross-correlation 
analysis on subsets of neurons and Schwann cells subdivided by their contact state. 
Neurons contacting another neuron (NC) presented 21.3% correlated pairs, versus 27.3% 
correlated pairs in neurons not contacting another neuron (NNC; Figure 2-4A). In SCs the 
numbers were 40.2% and 44.3% for those in contacting and non-contacting states, 
respectively. We then tested whether pooling data along the entire length of the axon 
masked any such effects at the leading edges of the cell (i.e., growth cone or 
lamellipodium); however, analysis of correlation at the edge (< 30 m) also failed to 
identify differences between the edge and the whole cell (Figure 2-4B). 
Identification of particle velocities in the experimental groups by contact state 
provided average positive particle velocities in NCs of 0.301 µm/min and in NNCs of 
0.394 µm/min (Figure 2-4C). In SCs, velocities were found to be 0.582 µm/s and 0.732 
µm/s contacting and non-contacting states, respectively. Neuronal velocities were 
significantly different from their SC counterparts (p< 0.05, Tukey’s t-test); however, 
despite a strong trend towards increased velocity in non-contacting SCs compared to 
contacting SCs, no significant differences were found within a cell type (Tukey’s t-test). 
Again, characterization of the velocity at the edge (< 30 m) failed to identify an edge 
28 
 
effect when compared to the whole cell (Figure 2-4D). Distributions of particle velocities 




Figure 2-4: Membrane correlation and velocity by contact type 
Percentage of correlated WGA pairs by cross-correlation along the entire projection (A) 
and within 30 μm of the edge (B). Values represent means ± SEM (n = 7-8). Average 
positive velocity of WGA particles along the entire projection (C) and within 30 μm of 
the edge (D) *p < 0.05 (v. Schwann cells without contact, ANOVA with Tukey’s post-
hoc test). Values represent means ± SEM (n = 7-8). ). Average negative velocity of WGA 
particles along the entire projection (E) and within 30 μm of the edge (F) *p < 0.005 (v. 
Schwann cells without contact, ANOVA with Tukey’s post-hoc test). Values represent 
means ± SEM (n = 7-8). Percentage of particles deemed stationary with velocity less than 
0.01 μm/s *p < 0.05 compared to contacting neurons, +p < 0.05 compared to non-
contacting neurons, (ANOVA with Tukey’s post-hoc test). Values represent means ± 
SEM (n = 7-8). 
 
There was observable contact state dependence witnessed in the average positive 
or negative velocities both along the entire cell or localized to the edge (Figures 2-4C-F). 
The percentage of stationary particles (those below 0.6 µm/min) was identified as an 
indicator of relative membrane immobility. In the case of neurons, NCs possessed 
91.51% stationary particles while NNCs had 88.96% stationary particles (Figure 2-4G). 
Particles of SCs were more mobile with only 46.33% and 36.27% of particles in SCCs 
and SCNCs identified as stationary. Using a two-way ANOVA, a strong cell type 
dependence was identified (p <0.00005, ANOVA) 
Subsection 4: Levels of the adhesion molecule talin in contacting versus non-
contacting cells 
The levels of the adhesion molecule talin were quantified by the intensity of 
immunostaining as an indirect measure of adherence (Figure 2-5B). NCs had the highest 
percentage of staining along their projections at 31.68%. NNCs were stained along 
28.79% with SCCs stained along 26.39% and SCNCs stained along 11.15%. Neurons 
overall demonstrate a trend towards more stable adhesions in the form of talin compared 
to SCs, though the development of contact in SCs also trends towards an increase in talin 
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densities. No significance was identified between any of the groups using both a two-way 
ANOVA and Tukey’s post hoc test, likely due to the low sample number.  
 
Figure 2-5: Talin immunostaining 
Immunostaining for talin levels (A) in neurons with contact (NC), neurons without 
contact (NNC), Schwann cells with contact (SCC), and Schwann cells without contact 
(SCNC). Quantification of immunostaining levels by thresholding (B) revealed no 
significance (ANOVA, p > 0.05). Scale bar, 10 m. 
 
Section 4: Discussion 
Using fluorescent WGA as a membrane label provides the unique ability to track 
regional membrane movement during the growth and migration of cells. Previously, 
membrane correlation has generally been studied on a much smaller scale, identifying 
extremely localized diffusion of individual particles in membrane patches and lipid rafts 
[113,114]. Applying time-lapse fluorescence microscopy to cells fluorescently labeled 
with WGA as a marker for the movement of membrane patches allows identification of 
membrane correlation and continuity on a larger scale. Earlier work has focused on the 
localization of membrane insertion and membrane flow [41-43]. Our study focuses on 
more stable regions of the membrane to identify the dynamics of whole cell mechanics 
during normal growth and function. 
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Subsection 1: Quantitative analysis of continuity in the membrane 
Multiple methods of analysis were used to identify correlation between particle 
pairs. Regression analysis was employed following the precedent of previous literature 
[86,101]; however, this method relies implicitly on a dependence of one particle on the 
other. In this study, because neither particle within a pair is explicitly dependent on the 
other, analysis using cross-correlation may provide a more appropriate characterization of 
the relationship. It was shown that independent of methodology, levels of correlation 
displayed similar trends (Figures 2-3A and 2-3B).  
Quantitative characterization and analysis of particle mobility allows for a more 
rigorous investigation due to the level of detail and number of identifiable parameters 
such as relative positions and velocities. Comparisons between these variables can be 
easily obtained to explore previously unidentified relationships and describe the 
mechanical connectivity. Additionally, quantitative analysis allows for efficient, unbiased 
processing of data to provide impartial results. In future studies, one might be able to 
comb through large sets of data and quickly determine localization of membrane 
expansion and contraction. 
Subsection 2: Influence of cell type on membrane correlation 
One particular finding of interest is that although both cell types possess strong 
bipolar morphologies, a cell type influence exists in the correlation of membrane patches 
when comparing SCs and neurons (Figure 2-3A and 3B). A major contributor to this 
difference is likely the mobility and cytoskeletal architecture of each cell type. While 
neurons of the CNS have been known to migrate along glia during development [115], 
this behavior opposes what is known to occur in the PNS, especially in DRGs where 
neurons secure their cell bodies and proceed to extend axons [116]. Once migrating SCs 
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become committed to a myelinating phenotype, their cytoskeletal composition changes 
and they lose their ability to migrate [93]. Additionally, non-myelinating SCs are known 
to respond to signals, such as NGF, during development and injury to migrate along 
axons in the PNS [93,117]. This migratory phenotype is consistent with the higher level 
of regional mobility in SC membranes compared to those of neurons (Figure 2-3E). It is 
therefore likely that the increased velocity is responsible for a portion of the correlation 
increase witnessed in SCs compared to neurons.  
In the case of SCs, there is obvious, movement along the entirety of the cell. 
While migrating, typically, the distal edge of the cell extends and the cell body follows 
with some regularity. Not only does this extension happen at a larger rate than that of 
axonal growth cones, the propagation of this movement is generally limited to a much 
smaller portion of the cell in neurons compared to SCs. Due to the mechanics of the 
movement, it is likely that higher levels of membrane correlation allows the SC 
membrane to mechanically compensate with the dynamic movement. It is of note that 
correlation of low velocity particles may be underestimated due to the inability to 
distinguish the relationship of truly stationary particles leading to their determination to 
be uncorrelated. 
Regional continuity in the movement of plasma membrane is likely to be 
influenced by the underlying cytoskeletal framework of the two cell types; however, the 
length scale over which such correlation occurs may be different from that in the 
cytoskeleton. Neuronal membranes were shown to possess a larger length-scale over 
which correlation occurs (Figure 2-3D); this length-scale is considerably larger than that 
previously reported for cytoskeletal continuity (<20μm; Chetta et al., 2010, Figure 6E 
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[101]) in a similar experimental model system. Microtubules of neurons average around 
100 µm whereas the microtubule networks of migratory SCs are much less mature with 
length scales around 20 µm [93,118]. The variation in correlation length-scale may be 
directly attributable to immaturity in the cellular cytoskeleton and dynamics therewith. 
Subsection 3: Influence of contacting state on membrane correlation 
While the establishment of contact was shown to limit the mobility of the 
membrane (Figures 2-4C and 2-4E), our data fails to identify a role for contact in 
affecting the correlation of the membrane in either cell type (Figure 2-4A). In neurons, 
although cell-adhesion densities increase upon contact, thereby limiting growth cone 
motility and initiating synapse formation, this does not appear to limit the overall 
continuity of the cellular membrane (Figure 2-4A) [119]. In SCs too, focal adhesions 
have been hypothesized to increase following the establishment of contact [34]. 
However, such contact in vitro has been established to be insufficient to induce 
myelination [104]. Furthermore, the induction of myelination, not simply the 
establishment of contact, is required for wide-scale cytoskeletal reorganization of all 
cytoskeletal classes [104,120]. It is therefore likely that much of the observed correlation 
at our intermediate resolutions (microns) is reliant, directly or indirectly, on cytoskeletal 
stability and organization in addition to the movement of the cell. To more specifically 
identify the influence of contact state, the specific changes in both movement and 
correlation were identified at the edge (Figures 2-4B, 2-4D, and 2-4F). The variation in 
the data between the edge and the overall cell is so small that this should serve to support 
the fact that contact establishment has no observable effect. 
As an initial step in understanding mechanisms underlying changes in mobility 
with contact, we analyzed the presence of talin, a cytoskeletal protein concentrated at 
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focal cell-substrate adhesions. While the average levels of talin along projections or in the 
vicinity of the cell terminal did not present significant differences across cell types, there 
was an identifiably lower amount of talin staining in SCs that had not established contact 
with other cells (Figure 2-5B). In SCs, though not neurons, talin levels are inversely 
proportional to the level of membrane correlation. This may also be a consequence of 
reduced adhesion in more mobile cells, though this hypothesis remains to be tested. It is 
possible that the establishment of focal adhesions compartmentalizes the membrane to a 
degree, limiting membrane correlation and continuity. Further investigation into the role 
of both cell-cell and cell-substrate adhesion, both of which change dramatically during 
myelination, fasciculation, and synapse formation [92,103,112], would be required to 
make a definitive statement on the role of adhesion on membrane correlation.  
Subsection 4: Differences in membrane velocity amongst cell types 
The major focus of this work was to test the regional correlation of movement 
rather than examine the mobility of freely diffusing lipids within the plasma membrane. 
However, it is instructive to place our results in the context of related studies both in 
neurons and non-neuronal cells. At first glance, our results appear very different from 
membrane addition and flow rates observed in previous experimental systems, to the 
point of being nearly an order of magnitude smaller [41,42]. However, a closer 
examination of differences in methodology and the experimental model provide some 
insight into these differences, and, in fact, suggest some conceptual consistency.   
A strong possibility exists that the brightly fluorescent regions we observed 
correspond with the approximately 30% of stable particles noted by Dai and Sheetz, 
which were posited to be attached to the cytoskeleton, but not considered in their analysis 
[41]. Such stable particles were also noted in other similar studies using larger beads 
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[36,37]. Furthermore, they identified retrograde flow of membrane in embryonic chick 
DRGs due to relative differences in tethering forces at both proximal and distal regions of 
the axon [41]. In contrast, the consistency in talin staining along the projections of 
postnatal rat DRG and SC in our cultures points to the likelihood of a more consistent or 
less predictable tension. This could provide additional rationale for the lack of observed 
membrane flow in our experimental system, and are consistent with the low average 
velocities but the relatively higher directional velocities that we observed. These 
observations are also consistent with observations in other classes of migratory cells that 
are known to not possess directed membrane flow [43]. A direct comparison of different 
cell types using identical experimental methodology may address some of these 
hypotheses. 
A key factor that could influence the interpretation of our data is the possibility 
that WGA is being internalized. Four observations suggest that this is highly unlikely. 
First, internalization was blocked methodologically by incubation of WGA during 
refrigeration. Second, immediately following this block, dextran co-incubated with WGA 
was internalized at the growth cone and cell body, but not along the axon. Third, rates at 
which these internalized dextran particles moved were not sufficient to deposit them 
along axons, following internalization at the growth cone, within the time frame of our 
movement analysis. Finally, we compared WGA particle movement in time-lapse movies 
captured immediately after blocking internalization versus those captured 4 hours later, 
during which time internalization may have occurred (Supplemental Figure 2-2D). Our 
data suggest that at the later time point, internalized WGA moves at a faster velocity and 
with more frequent changes of direction than at the earlier time point. This more mobile 
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sub-population of particles reflects similar movement to that of Rab5 during early phases 
of endocytosis [51].  
Section 5: Conclusions 
The methods presented here provide a unique look into large-scale membrane 
mobility. Quantitative analysis allows for unbiased conclusions about the membrane 
dynamics. The cellular membrane of SCs displays a markedly higher level of correlation 
amongst membrane patches compared to neurons. This relationship appears to correlate 
with increases in velocity and is inversely proportional to the presence of adhesive 
markers. These findings support an intuitive model where two mechanisms could work 
antagonistically to influence the level of membrane correlation and relative continuity. 
First, a higher velocity movement of the cell leads to increased membrane correlation due 
to directional forces generated by the cell to develop motion. Conversely, focal adhesion 
development and associated cytoskeletal stability would serve to resist these forces 
generated to develop motion.  
It would be interesting in future studies to further investigate the role of 
cytoskeletal filaments and their associated proteins with respect to membrane continuity, 
as well as compare the response of neurons and Schwann cells to the direct application of 
a load. Exploration of changes in SC membranes following myelination would also be an 








Section 6: Supplemental Figures 
 
Figure 2-1 (Supplemental): Control experiments 
Growth cone ruffling was observed in non-contacting neurons (A) as an indication of 
overall neuronal health, scale bar 10 m. Axonal blebbing (B) was observed in a limited 
number of neurons. These neurons were excluded from the study, scale bar 10 m. High 
velocity membrane movement was observed in axons that were given 4 hours to recover 
following WGA application (C), scale bar 20 m. To exclude internalized membrane, the 
4-hour incubation was removed from the protocol.  Cumulative histogram of individual 
positive particle velocities on neurons (D) *p < 0.0001 (v. no incubation, Kolmogorov-
Smirnov test). Confocal imaging of fluoresce revealed the absence of internalized WGA 






Figure 2-2 (Supplemental): Particle velocity histograms by cell type and contact 
state 
Additional histograms of positive (A) and negative (C) particle velocities (analogous to 
Figures 3F and 3G). Focused characterization of the velocities of particles in regions 
within 30 m of the edge (B and D) yielded little difference. Significant differences 
(p<0.05, Kolmogorov-Smirnov) are as follow: (A) NC vs. SCC, NC vs. SCNC, NNC vs. 
SCC, NNC vs. SCNC; (B) NC vs. SCNC, NNC vs. SCC, NNC vs. SCNC, SCC vs. 
SCNC; (C) NC vs. SCC, NC vs. SCNC, NNC vs. SCC, NNC vs. SCNC, SCC vs. SCNC; 
(D) NC vs. SCC, NC vs. SCNC, NNC vs. SCC, NNC vs. SCNC. 
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Chapter 3: Ribosomal trafficking in Schwann cells depends on 
early myelination cues 
Section 1: Introduction 
Schwann cells (SCs), a major cell type of the peripheral nervous system, are 
tasked with supporting neurons in numerous ways, from enhancing electrical conduction 
[121] to providing trophic factors for axonal growth and regeneration [23,122]. In this 
capacity, they possess a distinctive bipolar architecture; internode distances of up to 500 
μm require distances between the Schwann cell body and distal processes to reach over 
200 μm [123]. As in neurons, another polarized cell of unusual geometry [124], 
myelinating and unmyelinating SCs appear to synthesize particular proteins at the site of 
demand within projections, rather than in the cell body [48].  
In contrast to ER-bound ribosomes, which are mainly tasked with the production 
of membrane-associated or secreted proteins [125-127], cytosolic protein synthesis 
occurs on free ribosomes and is typically responsible for producing many proteins 
locally, including intracellular signaling molecules, transcription factors, and cytoskeletal 
elements [128]. Evidence of local protein synthesis in myelinating cells remains mostly 
indirect, based on the presence of mRNA in isolated polysomes and granules within both 
unmyelinating and myelinating glial cells [129]. Additionally, myelin basic protein 
(MBP) mRNA has been observed to be distributed throughout SC and oligodendrocyte 
projections [48-51], and radiolabeled MBP (2 min) appears early compared to the cell 
body-synthesized protein PLP (30 minutes) in the myelin fraction of oligodendrocytes, 
providing additional evidence for translation of MBP within the myelin fraction [52].  
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Lacking from our current understanding is how these free ribosomal populations 
are distributed in Schwann cells during development and how ribosomal distribution is 
influenced by Schwann cell interactions with neurons. Developing a better understanding 
of these mechanisms may provide better insight into protein synthetic dynamics as well 
as the stability of observed ribosomal structures, in preparation for translation of 
Schwann cell proteins as well as, intriguingly, those potentially transmitted to neurons 
[27,28]. We used quantitative biological and theoretical approaches to probe the 
hypothesis that the induction of myelination would increase trafficking of ribosomes, to 
account for the required increase in production of myelin associated proteins.  Expression 
of fluorescently labeled ribosomal subunits in primary Schwann cells allowed us to track 
ribosomal transport in real time, and quantify changes in patterns of ribosomal 
localization and transport during both their initial interactions with neurons in culture and 
in early phases of myelination. Multiple regression analysis and the development of a 
data-driven rate kinetic model enabled us to develop further insight into these changes. 
Our data suggest that stable ribosome-enriched foci appear early during Schwann cell 
projection extension and are maintained during early stages of myelination. However, 
transport of new ribosomes into projections slows upon induction of myelination, 
primarily due to increased conversion of anterograde (outward) moving particles to a 
stationary pool. 
Section 2: Materials and methods 
Subsection 1: Animal usage and euthanasia 
Animal usage was in accordance with protocols approved by the UCSD 
Institutional Animal Care and Use Committee (IACUC). Pregnant female rats were 
euthanized by asphyxiation with CO2 followed by confirmation via secondary means 
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(removal of major organs). P2 neonates were incapacitated with CO2 followed by 
euthanization via decapitation. 
Subsection 2: DRG collection and culture 
DRG culture methods were adapted from previously published methods [130]. 
Dorsal root ganglia (DRGs) were removed from E15 Sprague-Dawley rats in HBSS.  
DRGs were dissociated in trypsin for 30 minutes at 37°C.  Following trypsinization, 
samples were washed 3x in fresh pre-warmed media. DRGs (~30,000 per plate) were 
plated on laminin-coated glass coverslips placed within 24-well plates supplemented with 
500 μl of prewarmed DRG media consisting of MEM with 10% FBS, 2% B27, 1 ng/ml 
NGF, and 1 % Penicillin/Streptomycin.  One day post plating, culture media was 
supplemented with 1 ug/ml FdU to eliminate contaminating fibroblasts and Schwann 
cells.  Media was alternated every 2-3 days between FdU application and fresh media for 
a period of two weeks to obtain a mostly purified neuronal culture (Figure 3-1A). 
Subsection 3: Schwann cell isolation 
Schwann cells were isolated and cultured per previously published methods [130]. 
Primary Schwann cells were obtained from the sciatic nerves of ~10 P2 Sprague-Dawley 
rat pups (20 nerves). Nerves were dissected into 14 ml of L15 media then spun down at 
3000 rpm for 2 min.  Media was aspirated off and nerves were resuspended in 2 ml L-15 
and 1 ml 10 mg/ml collagenase type P and incubated at 37°C for 45 min, mixing every 10 
min.  Tissue was spun down for 2 min at 1000xg, media aspirated off and pre-warmed 
digestion solution added (3 ml 0.25% trypsin and 1 ml DNase [1.2 mg/ml]) Sample was 
incubated for 15 minutes at 37°C.  Following incubation, the reaction was halted by 




Figure 3-1: Experimental Design 
(A) Cell culture timeline. All experimental days reference days since Schwann cell 
addition to neuronal culture; Confirmation of myelination protocols and cell culture 
techniques was observed through immunolabeling: (B) DIC image of Day 14AA culture 
indicates several clusters of Schwann cells and neurons (stars) as well as fascicles of 
myelinated DRG axons (arrows); (C) MBP immunostain of Day 14AA culture shows low 
levels of MBP expression, indicative of early myelination; (D) DIC image of cultured 
Schwann cells at Day 1 (E) S100 immunostain identifies cultured Schwann cells; (F) DIC 
image of a single Schwann cell (star) abutting  neuronal processes; (G) SMI-31 
(phosphorylated neurofilament) immunostain identifies location of neuronal processes 




minutes at 1000xg followed by two washes with 10 ml of ice cold L15 media followed by 
1000xg centrifugations.  Samples were supplemented with 5 ml of media and triturated.  
Cells were spun down at 1000xg and media removed for transfection.  
Subsection 4: Transfection 
Nucleofection was performed according to manufacturer’s instructions (4D-
Nucleofector
TM
 System, Lonza AG, Switzerland) using P3 primary cell solution and 
program setting DC-100 to transfect. Either 3 μg of L4-GFP plasmid (a generous gift of 
Tim Krüger [131] or control GFP plasmid (Lonza AG, Switzerland) were used.  
Expression persisted for up to two weeks in culture. However, the percentage of cells 
expressing the plasmid decreased over time, as has been previously reported [132]. Thus, 
our experimental time course was conservatively chosen to span early phases of 
myelination, and includes cells from one day post transfection (Day 1) to cells one week 
post transfection (Day 7) (Figure 3-1A). 
Subsection 5: Induction of myelination 
Myelination was induced with ascorbic acid per published protocols [133]. On the 
fourth day of co-culture with neurons, Schwann cell media was supplemented with 50 
μg/ml ascorbic acid to initiate the process of myelination. Cells treated with ascorbic acid 
and observed were designated (Day 7AA) in contrast with untreated cells (Day 7 No 
AA). Myelination was confirmed using immunocytochemistry at day 14 (Figure 3-1C).  
Subsection 6: Immunocytochemistry 
Immunocytochemistry was performed at various developmental time points, using 
published protocols [2]. Samples were labeled with one or a combination of the following 
primary antibodies: mouse anti-S100 (Sigma-Aldrich S2532), mouse anti-SMI31 (abcam 
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ab24573), mouse anti-MBP, human anti-Ribo-P (Immunovision HPO-0100), mouse anti-
RPL4 (Sigma-Aldrich WH0006124M1), mouse anti-tubulin (Sigma-Aldrich T9026). 
Appropriate species specific fluorescently-labeled secondary antibodies were used to 
visualize primary antibody localization.  Secondary antibodies used included: Alexa 
Fluor 488-goat anti-mouse (Invitrogen A-11001), Alexa Fluor 594-goat anti-mouse 
(Invitrogen A-11032), Alexa Fluor 594-goat anti-rabbit (Invitrogen A-11037), and Alexa 
Fluor 594-goat anti-human (Jackson Immunoresearch 109-585-003). Desired samples 
were incubated for 30 minutes prior to mounting in Alexa Fluor 594-phalloidin 
(Invitrogen A-12381) to visualize actin. 
Analysis for co-localization was performed using ImageJ plugin JACoP.[134] 
Images were analyzed for overlapping expression using the Manders coefficient, which 
incorporates both position and fluorescence intensity into assessment of co-localization 
[135]. 
Subsection 7: Imaging 
Cells were imaged using a Leica SP5 system within an environmental chamber 
(Tokai Hit, Japan) that, for live-imaging experiments, enabled maintenance of the 
environment at 37°C and 5% CO2. Standard lasers and filters were used. An argon laser 
enabled excitation at 488nm with HeNe lasers for 594nm. Emission was captured 
between 500-550 nm (GFP, Alexa-Fluor 488) and 600-650 (Alexa-Fluor 594). Laser 
power and gains were adjusted to provide best images for each sample. 
Time course images of transfected cells were captured at 5 second intervals for a 
period of 5 minutes.  The capture rate and imaging period were chosen based upon 
several factors including anticipated transport rates, desired resolution, and minimization 
of photobleaching and phototoxicity.   
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Subsection 8: Image processing and analysis 
Custom Matlab (Mathworks, Inc.) programs were modified from previous studies 
[2,136]. to convert time course images into a kymograph. Kymographs allow for 
visualization of changes in an intensity profile of a 1-dimensional trace over time with the 
time variable displayed along the y-axis and cellular position along the x-axis.  
Kymograph traces in our analysis were made along the long axis of the SC projection 
allowing visualization of transport throughout the projection with a thickness of 9 pixels. 
Application of a standard deviation filter in MATLAB to processed kymographs enabled 
background and noise suppression with signal enhancement, by replacing a given pixel 
with the standard deviation of its surrounding 3x3 pixel neighborhood. At this point, the 
individual traces were reduced to a central 3-pixel thickness encompassing the centerline 
of the projection. Kymographs were analyzed for both ribosomal distributions along the 
projection as well as transport characteristics of mobile ribosomal populations.  
For characterization of ribosomal distributions, kymographs were averaged along 
the y-axis providing an average projection profile for the five minute imaging duration. 
The profile was manually segmented to separate the cell body from the projection for 
characterization. Stable populations of ribosomes were noted within the projections 
through identification of peaks in the average intensity above background fluorescence 
levels (>3x). Peaks within 5 pixels (~2.5 μm) were counted as a single peak to minimize 
double counting due to inherent noise from averaging. Average fluorescence levels were 
identified for both the cell body and projection regions.  Peak distance values were 
determined from identified peak locations and specified projection start. 
Transport parameters were computed based upon manual identification of mobile 
ribosomal particles with a continuous trajectory from frame to frame and an intensity of 
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at least 3x above background. Traces were made of moving particles, and parameters for 
each ribosomal particle were computed.  Mean particle parameters were computed and 
presented as average values. Net velocity was computed based on the aggregate distance 
traveled by all particles in a given sample divided by the time window of observation [6].  
This provides a reasonable surrogate for the collective level of transport conducted by a 
cell throughout the duration of the 5 minute imaging window. 
Subsection 9: Multiple regression analysis 
Multiple regression analysis was performed on the z-scored data of all individual 
traces within an experimental group. The dependent variable (net displacement) was 
regressed against the independent variables average velocity, total duration, anterograde 
velocity, anterograde duration, stationary velocity, stationary duration, retrograde 
velocity, and retrograde duration. Higher β-weights indicate a stronger contribution to the 
regression model.  
Subsection 10: Modeling 
A ribosomal transport model was implemented using a rate kinetics model to 
evaluate transitions from stationary, retrograde, and anterograde ribosomal populations. 
The model, modified slightly from its original form [137], used a system of coupled 
differential equations for each population: 





The model schematic can be seen in Figure 3-7. Particle amounts while modeled 
as concentrations within the equations refer to instantaneous particle counts. The model 
was implemented in MATLAB (MathWorks, Natick, MA) using the differential equation 
solver ode45 which implements a Runge-Kutta method with a variable step size. In order 
to find a unique best solution, rates were varied between 0.001 and 1.001 in 0.01 steps for 
each rate constant. Sensitivity analysis for each model parameter was performed by 
varying each parameter over its allowed range, and plotting model outputs. Best fit was 
determined by minimizing the mean square error (MSE) between modeled parameters 
and experimental data for net displacement and the number of particles in each state. 
Initial model fit was made using the time points untreated with ascorbic acid. A fit was 
then made between the Day 4 time point of the fit (when ascorbic acid was added) and 
the Day 7 treated group. Within the model, net velocity was calculated by multiplying the 
instantaneous particle populations of each state by the instantaneous velocity of the 
population for a given time step and summing the two populations. Experimentally 
measured velocities were fit using linear regression to provide an approximate 
instantaneous velocity (Table 3-1). 
Subsection 11: Statistical analysis 
In all cases a 1-way ANOVA was performed across all experimental groups (Day 
1, Day 3, Day 7 No AA, Day 7AA). Additionally, Tukey’s HSD was performed post-hoc 
to determine significant differences between individual groups of interest while 
accounting for multiple comparisons. Differences were considered significant for p < 
0.05. A minimum sample size of 7 was used for each group, corresponding to a statistical 




Table 3-1: Model parameters  
Constants for linear fits of velocities used in transport model for each experimental state 
(based on fits of experimental velocity data) 
 
Section 3: Results 
Subsection 1: L4-GFP transfection and ribosomal expression in Schwann cells 
We confirmed and characterized transfection of SCs with the L4-GFP plasmid 
(Figure 3-2A).  Only ~15% of cells were successfully transfected; however, comparison 
of transfected cells with fixed cells immuno-labeled for ribosomal protein L4 showed 
strong agreement in localization (Figure 3-2B). Of particular note was the punctate 
expression within the nucleolus and higher relative fluorescence within the cell body 
compared to the projection of the SC. Comparison with Ribo-P, a marker for 
phosphorylated ribosomes, showed strong co-localization outside of the nucleus (Figure 
3-2C). The expression profile of L4-GFP also differed greatly from that of GFP 
expression (Figure 3-2D), which was evenly distributed in low levels throughout the 
entirety of the SC. 
Subsection 2: Ribosomal expression characteristics within Schwann cell 
projections  
Following successful transfection, SCs associated with neurons were identified 
based on the position of cell bodies and projections of each cell type. We investigated 
these cells to determine the development of ribosomal distributions within SC projections 
over time and following myelination induction (Figure 3-1A). We compared early (Days 
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1 and 3) and late (Day 7 No AA) time points for untreated cells, and for the late time 
point, also cells treated with ascorbic acid at day 4 to induce myelination (Day 7AA). 
 
Figure 3-2: Transfection and ribosomal labeling  
(A) Transfected Schwann cell expressing L4-GFP (magnified in inset); (B) Schwann cell 
immunostained with anti-L4; (C) Schwann cell immunostained with anti-Ribo-P shows 
strong extra-nuclear co-localization with L4 expression; (D) Transfected Schwann cell 
expressing GFP (magnified in inset) shows continuous low-level expression throughout 
cell, including the nuclear compartment, and differs from L4-GFP labeling pattern; Scale 
bar:  50 µm 
 
The ratio of cell body fluorescence to projection fluorescence was used to 
determine any difference in bulk localization of ribosomes. This ratio was calculated for 
sub-saturation fluorescence, and was independent of any cell to cell differences in 
fluorescence expression. The ratios at each time point were consistent, falling between 
0.406 and 0.429 (p = 0.486; One-way ANOVA, Figure 3-3A), suggesting no net increase 




Figure 3-3: Projection ribosomal distributions  
Ribosomal expression in the projections of Schwann cells remained relatively consistent 
throughout the experimental proceedings according to a number of metrics: (A) The ratio 
of fluorescence in the projection compared to the cell body remained consistent 
throughout the experimental groups; (B) The number of observed ribosomal peaks (or 
puncta) did not vary significantly throughout the experimental groups; (C) The distance 
between peaks varied albeit not significantly throughout the experiment (Means ± SEM). 
Statistics: 1-way ANOVA. 
 
Bright, stationary ribosomal patches dotting the Schwann cellular projection were 
consistently observed at each time point. The peaks were characterized by a minimum 3x 
increase in fluorescence over the average projection expression level. The number of 
these peaks did not change amongst the experimental groups (between 2.2. and 3.4; p = 
0.77; One-way ANOVA, Figure 3-3B).  Additionally the peak to peak distance did not 
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vary (p = 0.605 One-way ANOVA, Figure 3-3C). Several additional morphological and 
fluorescence parameters of interest, including projection length, raw fluorescence, and 
distances of peaks from cell bodies were also calculated (Table 3-2). These also yielded 
no significant differences. This evidence points to an early establishment and inherent 
stability of the ribosomal clusters following SC alignment with neurons, independent of 
time or early myelination.  
 
Table 3-2: Projection data  
Additional values from projection analysis show little variability between experimental 
groups, p-values based on 1-ANOVA of experimental group 
 
Subsection 3: Cytoskeletal characteristics of ribosomal clusters in Schwann cells 
Based on observations of apparently stable ribosomal clusters, we tested whether 
any particular cytoskeletal components were associated with local ribosomal clusters. In 
neurons, previous reports indicated high densities of F-actin subjacent to ribosome-
enriched periaxoplamic ribosomal plaques (PARPs) [62]. We therefore tested whether a 
similar phenomenon also occurred in SCs, by examining co-localization of 
immunolabeled L4 and phalloidin-labeled F-actin. We did observe bright regions of actin 
along the SC projection, interspersed with dim regions, enabling analysis of co-
localization with ribosomal clusters. However, L4 clusters in SC projections showed no 
specific co-localization or apparent proximity to F-actin in SCs alone (Manders = 
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0.179±0.082), in the presence of neurons without induction of myelination (Day 1; 
Manders = 0.341±0.288) and in the presence of neurons following induction of 
myelination (Day 7AA; Manders = 0.197±0.113) (Figures 3-4A-C). We also examined 
localization of RPL4 relative to microtubules, indicated by tubulin. However, fluorescent 
intensity of tubulin was consistent along axons at the imaged resolution, and thus 
precluded any analysis of co-localization (Figure 3-4D).  
 
Figure 3-4: Cytoskeletal distributions in Schwann cells  
(A) Schwann cell immunostained for L4 shows expression throughout the projection with 
specifically punctate regions (arrows) corresponding to ribosomal rich regions; (B) 
Phalloidin staining highlights cortical regions rich in actin (arrows) but not necessarily 
corresponding with ribosomal rich regions (C); (D) Tubulin immunostain revealed 
consistent ubiquitous expression throughout Schwann cells showing no preference for 
ribosomal puncta; Scale bar:  50 µm 
 
Subsection 4: Ribosomal transport characteristics within Schwann cell projections  
Though densities were apparently stable, movies of L4-GFP dynamics, captured 
using time-lapse fluorescence microscopy, revealed movement of less intense L4-GFP 
puncta between densities. Thus, to examine whether ribosomal transport contributed to 
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the maintenance of densities, we next quantitatively characterized the movement of L4-
GFP using kymograph analysis, which allowed the observation of moving L4-GFP 
particles, and the characterization of puncta directionality, velocity, and duration of 
movement (Figure 3-5). Individual puncta were treated as single particles, independent of 
fluorescence intensity.  
The summation of net displacement for each individual L4-GFP particle within a 
given movie offers a summary of directionality and extent of movement within a cell 
during our imaging period. Normalization of this displacement to the imaging duration 
yields net velocity, which enables comparison with bulk transport rates captured over a 
longer time frame [2,6]. There are significant differences in net velocity of ribosomes 
over the course of Schwann cell development (p = 0.0038, One-way ANOVA, Figure 3-
6A). In particular, though ribosomal transport is anterograde (away from the Schwann 
cell body) at all time points, ribosomal transport at Day 7 increases in the absence of 
ascorbic acid, but is suppressed in the presence of ascorbic acid. (Mean ± SEM; No AA: 




Figure 3-5: Kymograph development  
(A) Schwann cell projections were cropped and traced to develop (B) a kymograph (y-
axis: time, increasing downward; x-axis: position along the projection, with anterograde 
to the right); (C) Trajectories for puncta observed in continuous frames were traced on 
the kymograph to identify ribosomal movement throughout the projection, and allow for 
quantification of transport parameters during the course of the experiment; Scale bar:  20 
µm, duration 5 minutes. 
 
We further examined individual transport parameters to determine their contribution to 
net displacement/velocity in each experimental group. The comprehensive data set, 
including statistical analysis, is summarized in Table 3-3. For clarity, we discuss key 
findings below.  
 
Table 3-3: Ribosomal transport data 
Transport data values from transport analysis showing variability among velocities and 
particle distributions between groups, p-values passed on 1-ANOVA (Tukey HSD, p < 
0.05 compared to *Day 1, ^Day 3, †Day 7 – No AA) 
 
The average ribosomal velocity was also dependent upon the developmental state 
of the Schwann cell (p = 0.0025 One-way ANOVA, Figure 3-6B). Most notably, there 
was a significant reduction in average velocity from Day 3 (0.56 μm/s) to Day 7 (No AA: 
0.25 μm/s; AA: 0.22 μm/s) irrespective of ascorbic acid treatment (Day 3 – Day 7 No 
AA: p = 0.041; Day 3 – Day 7 AA: p = 0.004, Tukey’s HSD). While the reduction in 
average velocity might be expected in the case of Day 7AA, where net velocity is also 
reduced, this was unexpected in the case of the untreated Day 7 group, where net velocity 
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in fact increases. This apparent paradox indicates that other phenomena are integral in 
determining the net velocity. 
Average particle run durations varied between 24 and 33 seconds in the 
anterograde direction and 21 and 35 seconds in the retrograde direction. Though there 
were no significant differences in particle durations in either direction (Figure 3-6C), 
interestingly, durations in each direction seemed to mirror one another, with the ratio of 
anterograde to retrograde durations confined to a narrow range of 0.93-1.12. This may 
indicate that variations in duration could result from a more systematic reduction in 
ribosomal transport regardless of directionality. 
A final component of net velocity is the number and proportion of particles being 
transported in each direction. There were significant differences in both particle 
populations (Anterograde: p = 0.006; Retrograde: p = 0.000006, One-way ANOVA, 
Figure 3-6D). Of note in the case of the anterograde particles is the significant increase in 
anterograde particles from Day 3 (5.125 particles) to Day 7 (No AA: 8.25 particles) in the 
absence of ascorbic acid (p = 0.005, Tukey’s HSD), but not the presence of ascorbic acid 
(AA: 5.6 particles; p = 0.918, Tukey’s HSD). This increase in particle number thus may 
be a key factor contributing to the observed increase in net velocity. 
Subsection 5: Multiple Regression 
We performed multiple regression analysis on a particle by particle basis to 
determine the individual contributions of each component measurement (independent 
variables) to the resultant net velocity (dependent variable). A complete summary of 
regression results is found in Table 3-4. At early time points, anterograde velocity had a 
strong influence on net velocity (Day 1: 0.431; Day 3: 0.474), with additional 






Figure 3-6: Ribosomal transport measures  
Kymograph analysis provided a clear picture of the dynamics of ribosomal transport. (A) 
Net velocity, a measurement that provides a relative comparison of the bulk transport 
occurring in the cell, showed increased levels after 7 days. These levels were decreased 
when the cultures were treated with ascorbic acid indicating an effect of this treatment 
and early myelination on ribosomal transport; (B) In both day 7 treatment groups, the 
average velocity was decreased compared to day 3; (C) Anterograde and retrograde 
durations varied over the course of the experiment but failed to show any significant 
differences; (D) The number of anterograde particles increased after 7 days in the 
absence of ascorbic acid compared to both the day 3 and day 7 ascorbic acid treated 
groups. Additionally, there was an increase in retrograde particles in both the day 7 
groups compared to the earlier time points, likely influencing the observed changes in net 







duration: -0.595; Day 3 anterograde duration: 0.474). At later stages, irrespective of 
ascorbic acid treatment, directional (anterograde) duration continued to contribute most 
strongly to net velocity (Day 7 AA: 0.630; Day 7 no AA: 0.925). Though the effect of 
anterograde velocity was sharply diminished, average velocity also contributed strongly 
to the model (AA: 0.525; No AA: 0.480). Thus, under the assumption that each parameter 
is modulated, at least partially, by a different set of biological influences, these results 
suggest that regulation of ribosomal transport in Schwann cells evolves temporally, but is 
not influenced by early myelination.  
 
Table 3-4: Multiple regression  
β-weights for multiple regression of z-scored data for independent variables regressed 
against the dependent variable net velocity show a shift from anterograde velocity 
dependence at early time points (Days 1 and 3) to anterograde time dependence at later 
time points (Day 7) 
 
Subsection 6: Ribosomal Transport Model 
A limitation of the narrow temporal window during which transport was assessed 
as well as a finer understanding of factors underlying outcomes from multiple regression 
analysis was an inability to examine directional transitions in particle movement. Thus, 
we developed a simple yet informative kinetic model, driven and validated by our 
experimental data, which was captured over a time frame of minutes, on net transport, 
which was measured over a time frame of days (Figure 3-7). The model determined a set 
58 
 
of rate constants that best fit experimental parameters for net velocity and the number of 
anterograde and retrograde particles, based on computed mean squared error. Numerical 
solution of the system of differential equations was stable. Model fits were extremely 
strong (No AA: MSE = 0.068; AA: MSE = 0.0018), and were unique within the wide 
range of allowed parameter values. Sensitivity analysis was also performed for each rate 
constant over this range of values (Supplementary Figure 3-1), and revealed that the 
model was most sensitive to changes in k+1 followed by k+2. 
The transition of rate constants upon addition of ascorbic acid provided 
information about the shift in ribosomal transport during onset of myelination. In both 
cases the rate of conversion from stationary to anterograde particles remained 
comparatively stable (k+1, No AA: 0.151; AA: 0.181). This was not the case for 
retrograde particles, which showed a large decrease in conversion from stationary to 
retrograde particles (k+2, No AA: 0.961; AA: 0.281), suggesting increased particle 
retention within projections. Further, the rate of conversion back to stationary increased 
dramatically with the addition of ascorbic acid for both anterograde (k-1, No AA: 0.001; 
AA: 0.441) and retrograde particles (k-2, No AA: 0.611; AA: 0.761), consistent with 
observed decreases in transport durations bidirectionally. Cumulatively, these results 
suggest that the increases in k-1 and k-2 are the likely drivers of decreased anterograde and 
retrograde particle number, as well as net velocity following induction of myelination. 
Section 4: Discussion 
The localization, dynamics, and activity of protein synthetic machinery have 
received increased attention in neurons [6,48,124,138,139], motivated in large part by the 
demands imposed by neuronal polarity and geometry. Local protein synthesis has been 
less extensively studied in Schwann cells, though they also extend long projections, and 
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thus also face similar metabolic, structural, and biochemical demands [48,52,123]. 
Additionally, recent evidence has suggested that Schwann cells are a source of mRNA 
and ribosomes for neurons recovering from injury, providing additional rationale for 
localizing protein synthetic machinery to SC projections [27,28].  
 
 
Figure 3-7: Rate kinetic model of ribosomal transport  
(A) Schematic of the rate kinetic model shows possible particle states and transition rate 
constants between the three states; (B) Plotting of the optimized model (lines) shows 
strong agreement with experimental data (points); (C) Following ascorbic acid treatment 
the rate of conversion from anterograde to stationary (k-1) increased while the rate of 
conversion from stationary to retrograde decreased (k+2), leading to the overall reduction 




This study used a combined experimental and theoretical approach to examine the 
localization and movement of ribosomes within the projections of Schwann cells at high 
resolution. While several important studies have documented the presence of mRNA and 
ribosomes in SC projections [48-52], the development and plasticity of ribosomal 
populations locally remain unknown. Our overall hypothesis was that local populations 
would be developed early during projection extension to enable projection outgrowth. 
However, such populations would then require supplementation, both for maintenance, 
given the ~40 hour half-life of ribosomes [140], as well as to sustain increased 
interactions with neurons, which may be stably myelinated for years [141]. Our results 
support our original hypothesis of anterograde transport of ribosomes developing 
ribosomal populations in the projections of Schwann cells during initial projection 
elongation. In early phases of myelination, ribosome trafficking decreases slightly as 
expected, in line with a shift towards a maintenance regime. 
Subsection 1: Stable ribosomal populations 
Localization of L4-GFP in transfected Schwann cells showed strong agreement 
with immunolabeled L4. Two characteristics of ribosomal expression in Schwann cell 
projections, seen both in transfected cells and immuno-labeled cells, are of particular 
note. First, similar to MBP mRNA distributions described previously,[48,50,51] there 
was a level of punctate ribosomal expression throughout the projection. It is possible that 
these ribosomes are associated with RNA granules of varying size and function, as 
suggested for oligodendrocytes [142]. Second, there were 2-3 stable peaks of high 
fluorescence intensity within each Schwann cell projection, likely pointing to locations of 
ribosomal clustering. These peaks were apparent upon initial projection extension on day 
1 and persist throughout the seven days of observation both in the presence and absence 
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of ascorbic acid. This pattern too is similar to MBP mRNA densities within SC 
projections [48]. Future studies will reveal whether ribosomal densities synthesize 
proteins for stages of myelination or participate in ribosomal transfer to neurons[27,48] at 
structures yet to be formed. For instance, Schmidt-Lanterman incisures have been 
suggested as the region of ribosomal transfer following injury and occur at similarly 
spaced intervals (~25-30 μm) [143] as the observed ribosomal clusters [27,143]. 
Interestingly, while protein synthesis does not appear to extend into the Schmidt-
Lanterman incisures there does seem to be significant ribosomal localization to the 
surface network in the region adjacent the incisures [48]. 
To probe a possible structural basis for observed ribosomal densities, cells were 
co-labeled for RPL4 and cytoskeletal components. In neurons, ribosomal clusters 
(periaxoplasmic ribosomal plaques) are observed within axons and cluster around regions 
enriched in F-actin [62]. Similarly, Schmidt-Lanterman incisures are enriched in F-actin 
[27,28,144]. However, co-labeling of ribosomal subunits with F-actin and tubulin failed 
to display any obvious co-localization with ribosomal clusters (Figure 3-4). On the other 
hand, it is possible that a specific set of actin- or tubulin-associated proteins rather than 
the filaments themselves may play a role in docking or sequestering ribosomes [145]. 
Subsection 2: Ribosomal movement 
By Day 1 after neuronal contact, newly synthesized ribosomes containing L4-
GFP were already distributed throughout Schwann cell projections. Additionally, 
distributions revealed minimal changes between Day 1 and Day 7, in the presence or 
absence of ascorbic acid. Though it was somewhat surprising that ribosomal densities 
were stabilized so rapidly, also of interest was the activity of more dynamic populations 
of directionally moving ribosomes observed using time-lapse microscopy. Kymograph 
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analysis, which captured ribosomal transport characteristics at each experimental time 
point at high resolution, enabled us to quantify and compare transport parameters in 
greater detail. 
Individual transport parameters were integrated into an estimate of net movement 
(net velocity) of ribosomal populations, which served as a rough surrogate for ribosomal 
demand at a given stage of growth or myelination. The nucleus was the source of newly 
synthesized fluorescent ribosomal subunits, and as such explains the net anterograde 
velocities for each experimental group. Bulk rates were ~0.1–0.3 μm/sec (~8–25 
mm/day), which corresponds to an intermediate rate of transport in a neuron [146]. 
Interestingly, at early time points, the net velocity remained quite stable, but diverged at 
Day 7, dependent upon ascorbic acid treatment; ascorbic acid treatment led to an overall 
reduction in net anterograde velocity, whereas the absence of ascorbic acid led to an 
increase. 
The cellular processes driving reduced net velocity in the presence of ascorbic 
acid are mostly unexplored. Reduced ribosomal demand may simply represent a more 
focused diversion of translational machinery to the myelination process [33]. On the 
other hand, several Schwann cell activities appear to be coupled to early stages of SC-
neuron contact and myelination. Structurally, neuronal contact alters the nucleation, 
polarity, and distribution of microtubules within myelinating Schwann cells [147]. In 
addition, consistent with reduced cellular extension and crawling during neuronal 
interactions, mobility of Schwann cell membranes and their associated cytoskeleton is 
reduced and adhesion is enhanced [2,148,149]. It is not inconceivable that such structural 
changes during early stages of myelination could influence the directionality, duration, 
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and overall levels of ribosomal transport. Indeed, initiation of myelination in regenerating 
nerves results in altered expression and distribution of several genes and proteins in 
Schwann cells, including neurofilaments [150],  TGF-beta [151], P0 glycoprotein [152], 
and ion channels [153].  
While there are drastic changes in net velocity with the initiation of myelination, 
the average anterograde and retrograde velocities did not change, suggesting that the 
regulation of molecular motor activity is changed, not the responsible motors themselves. 
While it is unclear which motors are responsible for ribosomal transport in Schwann 
cells, in other cellular systems the distribution of ribosomes depends on early endosome 
trafficking of both kinesin-3 and dynein [154,155]. Parameters that might change include 
binding affinities, number of available motor proteins, and initiation of transport all of 
which would affect net velocity but not the individual components of velocity [156]. The 
observed decrease in ribosomal trafficking is mostly attributable to the increased levels of 
retrograde moving particles. The increase in retrograde particles at Day 7, for both 
ascorbic acid-treated and untreated cells, are perhaps due to ribosomal recycling [157]. 
However, the net velocity remains positive at these times indicating that ribosomes are 
still required in the periphery and needed to maintain and replenish the stable ribosomal 
pools. 
Subsection 3: Theoretical modeling of ribosomal transport 
To further understand differences in transport, we used our high-resolution 
assessment of transport to develop and validate a simple, yet powerful, data-driven rate 
kinetic model of ribosomal transport. This model was particularly effective at describing 
the transfer of particles from one movement state (stationary, anterograde, or retrograde) 
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to another, providing insight into underlying transport dynamics not amenable to other 
types of analyses.  
For example, population analysis indicated that both anterograde and retrograde 
populations decreased, and as a consequence, the magnitude of net velocity was also 
reduced. Our model enabled us to assess whether these reductions in anterograde and 
retrograde populations resulted from increased transition from moving to stationary 
particles, decreased transition from stationary to moving particles, or both. For our case, 
the model revealed an increased rate of conversion from anterograde to stationary (higher 
k-1), a decreased rate of conversion from stationary to retrograde (lower k+2), and a 
slightly higher rate of conversion from retrograde to stationary (higher k-2) upon addition 
of ascorbic acid. These three changes thus drove the observed reduction in bidirectional 
movement and net velocity.  
The model also raises hypotheses about different mechanisms for the decrease in 
both anterograde and retrograde populations. The decreased recruitment of retrograde 
particles may result from decreased recruitment of motor proteins and a desire to 
conserve established ribosomal populations within the projections. The increased 
conversion of anterograde particles to stationary may be resultant of myelin compaction 
and other restrictions on transport within the projection compartment, a systemic effect 
that could additionally affect retrograde transport. Such possibilities may be considered 
and tested in future experiments.  
Section 5: Conclusions and future directions 
This study provides a first quantitative look into the establishment of ribosomal 
populations within Schwann cells following neuronal contact and myelination, and 
transport changes associated with a hypothesized change in demand for a local protein 
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synthesis source. While others have shown that proteins are synthesized locally in 
Schwann cell projections and are required for myelination, we are the first to observe, 
quantify, and model the process dynamics during early development and myelination. 
The observed ribosomal transport decrease into the Schwann cell projection is likely tied 
to a decrease in demand for protein synthesis. However, many questions remain to be 
answered about how and why such dynamics occur, including which motor proteins are 
at work, the effect of early and late myelination on local protein synthesis, and the role, if 
any, early ribosomal localization may have on the proposed process of transcytosis [27]. 
Our initial findings open the possibility for a number of future studies that might be 
integral in developing translational clinical solutions for nervous system disease and 
injury.  
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Figure 3-1 (Supplemental): Variation of model rate constants  
Model traces for varying rate constants show degree of sensitivity for the unique solution. 
No AA groups were highly sensitive to both forward rate constants, k+1 (A) and k+2 (C), 
yet slightly less sensitive to variations in both reverse rate constants, k-1 (B) and k-2 (D). 
Similar results held for parameter variations in the AA treated model with higher 
sensitivity to changes in both forward rate constants, k+1 (E) and k+2 (G), and lower 




Chapter 4: Nerve strain correlates with structural changes 
quantified by Fourier analysis [3] 
Section 1: Introduction 
Peripheral nerve deformation affects electrophysiological function. Excess 
deformation results in functional deficits and the amount of strain dictates the 
reversibility of deficits [55,158,159]. This concept is particularly important during repair 
of severed nerves or limb lengthening procedures. Surgeons rely primarily on their 
experience and “feel” when they determine the appropriate tension for nerve 
reattachment [160,161]. Though tension-free repairs are a clinically accepted standard, 
some studies suggest that a modest level of strain can benefit nerve repair [78] and may 
even enhance neuronal function and promote survival [162]. Therefore, the ability to 
accurately and objectively monitor physiological strain may ultimately be of clinical 
utility. 
Originally identified in 1781 [163], one can observe the bands of Fontana, a 
distinct optical phenomenon that results from undulations in axonal tracts and their 
surrounding connective tissue [58,164-166]. The periodicity of bands of Fontana varies 
with strain; they ultimately disappear at ~14% strain (8% beyond resting strain) in the 
sciatic nerve of rats [164], which correlates with functional loss [55,158,159]. Thus, 
bands of Fontana may provide a sensitive structural predictor of nerve function. 
We report an automated Fourier-based image processing method to quantify 
periodicity of bands of Fontana in rat sciatic nerves from digital images.  Positive 
correlation between periodicities and applied strain was observed. Application of this 
method to immuno-labeled longitudinal sections of nerves at varying strain provide a 
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structural correlate for changes in the bands of Fontana, and demonstrate the versatility of 
the analytical method.  
Section 2: Methods  
Subsection 1: Animals and tissue collection 
Sciatic nerves were excised from 8 3-month old male Sprague-Dawley rats 
(Charles River Labs).  Procedures were approved by the UCSD Institutional Animal Care 
and Use Committee.  Six nerves from 3 animals were examined for in situ and severed 
studies. Following sacrifice, sciatic nerves were exposed, and in situ images of banding 
patterns at relaxed knee and ankle joint angles were collected (85-95° each).  Nerves 
were then transected just proximal to the trifurcation, and images were obtained of the 
severed nerve. Nerves were then excised 15 mm proximal to the site of transection.  
Three nerves, 1 from each animal, were pinned to cork board and imaged at 0% (prior to 
stretch), 10%, and 20% strain. 
Subsection 2: Imaging 
Bands of Fontana were imaged using a D5100 digital camera with a DX SWM 
VR Aspherical ∞ - 0.28m lens (Nikon). Histological sections were imaged with a Leica 
SP5 confocal imaging system and a 10x objective (resolution of 3.027 μm/pix). An argon 
laser enabled excitation at 488nm. Emission was captured between 500-550 nm.  Vertical 
stacks of ~24 images were acquired for each sample, with section thickness of 0.5-0.7 
μm. 
Subsection 3: Histology 
 Nine separately excised nerves from 6 specimens were pinned at specified 
strains, flash-frozen in liquid nitrogen-cooled 2-methylbutane for 2 minutes, and stored at 
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-80°C. Excised nerves were embedded in OCT, sectioned longitudinally and placed on 
Superfrost® Plus slides (Fisher 12-550-15).  
Subsection 4: Immunostaining 
Triplicate washes were performed in PBS.  Samples were permeabilized with 
0.2% Triton-X 100 in PBS for 5 minutes, washed, blocked with 10% FBS and 3% BSA 
in PBS for 30 minutes at room temperature, washed, and incubated with a monoclonal 
primary antibody targeting myelin-basic protein (MBP) (MAB382, Millipore) for 1.5 
hours at room temperature. Samples were then washed and incubated for 2 hours in 
Alexa Fluor 488-goat anti-mouse secondary antibody (Invitrogen A-11001). Primary and 
secondary antibodies were diluted in blocking solution (1:200). 
Subsection 5: Signal processing 
Images were cropped and contrast enhanced to visualize bands in ImageJ (NIH) 
(Figure 4-1A). Cropped images were analyzed using a custom Matlab (Mathworks Inc.) 
program. Images were treated as two-dimensional matrices, with 8-bit pixels possessing 
an intensity normalized between 0 and 1.  For each horizontal image row, using logic 
similar to subtracting DC-offset, a smoothed intensity trace [“smooth” function, Lowess 
method, span of (row length – 1)] was subtracted from the raw intensity profile to 
minimize zero-frequency artifacts during subsequent analysis (Figures 4-1B and 4-1C). A 
fast Fourier transform of this trace provided a peak frequency corresponding to the 
frequency (reciprocal of peak-to-peak distance) of bands of Fontana (Figure 4-1D) or 
axonal undulations. Residual zero-frequency peaks were ignored. The average frequency 









Figure 4-1: Correlation of band frequency with nerve strain 
A: Sample of cropped section used to identify bands of Fontana frequency; bar = 1 mm 
B: Plot of sample trace and corresponding smoothed function from custom MATLAB 
program C: Plot of sample trace offset by smoothed trace, providing a waveform that 
reflects around 0 D: Sample Fourier power spectrum used to identify peak frequency of 
each trace E: Samples of bands of Fontana imaged in situ and following transection; bars 
= 1 mm F: Average frequencies of bands of Fontana between severed and in situ samples 
(Mean ± SEM, *p < 0.05) G: Frequency changes with varying strain in histological cross-
sections and bands of Fontana in fresh nerve (Mean ± SEM) H: Longitudinal nerve slice 
stained against MBP and projected into XZ plane between dotted lines.  Solid line 
indicates smoothed fit of the maximal intensity location shows axonal undulations in the 
Z-direction; bar = 500 μm. Intensity plot of maximal intensities along projection reveals 
regional agreement between decreased intensity and axonal undulations designated by 
arrows. 
 
Subsection 6: Statistics 
Means were compared using t-test or ANOVA with  = 0.05 for hypothesis 
testing. Strain and frequency correlations were tested using linear regression. 
Section 3: Results  
In situ, bands of Fontana were periodic but appeared slightly disjointed and 
blurred. Bands appeared sharper and narrower upon severing the nerve (Figure 4-1E), 
which resulted in a 10% recoil of the nerve and a corresponding 60% increase in band 
frequency. (Figure 4-1F; P <0.05, unpaired t-test, n = 5 or 6). 
To correlate nerve strain with band frequency, we stretched excised nerves by 
10% and 20%. Comparison of the means revealed a significant effect of strain on 
frequency (P < 0.05, 1-way ANOVA, n = 3), and a strong linear relationship between 






 = 0.829; P < 0.05, 
regression, n = 9). To investigate a structural basis for bands of Fontana, Fourier analysis 
was applied to longitudinal sections immuno-labeled for MBP. Alternating light and dark 
regions indicated waviness in the perpendicular plane, as confirmed by three-dimensional 
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reconstruction (Figure 4-1H). Higher variability compared to intact nerves, possibly due 
to varying planes of undulation, resulted in an underpowered statistical comparison. 
Nevertheless, a trend similar to that in fresh nerve was observed at low strains. Increased 
frequencies at large strain may result from observed structural damage incurred at super-
physiological strains. Manual measurement of frequencies in both whole nerve and 
sections confirmed the accuracy of computed frequencies (e.g., Figures 4-1E and 4-1H). 
Section 4: Conclusions 
Using Fourier analysis, we successfully correlated increases in nerve strain with 
decreased frequencies of bands of Fontana and axonal undulations. These relationships 
are consistent with the concept that axons first unravel within deformed nerves to 
minimize their exposure to tensile loads. Differences in the magnitude of bands of 
Fontana and axonal undulation frequencies may indicate that additional structures 
contribute to bands of Fontana, such as superposed undulations of perineurial structures 
ensheathing fascicles [165]. Crimped epineurial collagen has been posited previously to 
contribute to bands of Fontana. This is unlikely, as crimp frequency is higher than axonal 
undulations [167]. A comprehensive three-dimensional study of nerve architecture will 
further clarify the relationship between structural elements and bands of Fontana.  
Methodologically, similar Fourier-based techniques have been used to identify 
periodic patterns in other tissues, including tendon and skeletal muscle [168-170]. Our 
approach is both accurate and objective and thus has considerable value towards 
understanding structure-function relationships in the nervous system and guiding the 
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Chapter 5: Strain induced mTOR signaling leads to enhanced 
protein synthesis in Peripheral nerves 
Section 1: Introduction 
Excessive tensile strain (stretch) or high strain rates can damage peripheral nerves 
and their component neurons, often irreversibly [55,56]. On the other hand, neurons also 
possess a remarkable ability to accommodate and respond to moderate levels of tensile 
loading. Nerves are stretched during rapid phases of organism growth [171], bear acute 
strains up to 25% during joint movement [54], and also adapt to more persistent strain, 
such as that occurring during limb lengthening [71]. Consistent with the latter, in vitro 
evidence suggests that strained axons can increase both their growth capacity and rate of 
elongation [75-77].  
These concepts have recently been translated into strain-based neuroregenerative 
strategies, with varied success [21,78,172]. Limiting our ability to optimize strain-driven 
regenerative strategies, though, is a poor understanding of biological mechanisms 
underlying neuronal response to strain. Axons gain volume rather than simply thinning 
while under strain [173], and thus require an increase of cellular material to support this 
expansion. Such a response is analogous to that occurring during axonal outgrowth 
during development or following injury, in which the production of many proteins, 
including those associated with the cytoskeleton, is increased  [66,174,175].  
Local protein synthesis provides an efficient way to mobilize structural elements 
required for increased neuronal volume. To this end, a number of mRNAs encoding 
cytoskeletal proteins are present locally within the axonal compartment, including β-
actin, tubulin, and neurofilament heavy subunit (NF-H) [66-68]. These transcripts appear 
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to be translated under conditions of stress. For example, severed axons require axonal 
protein synthesis to regenerate [69,81,82], in an mTOR dependent manner. Consistent 
with these findings, suppression of PTEN, an inhibitor of mTOR, enhances axonal 
elongation [70]. A role for mTOR in regulating strain-associated axonal expansion has 
not yet been tested. However, several other tissue systems, including skeletal and cardiac 
muscle, respond to strain by activating mTOR-dependent protein synthetic pathways , 
which are initiated by FAK phosphorylation [79,80].  
Considering the importance of mTOR in axonal extension as well as its role in 
responding to strain in non-neuronal cells, we hypothesized that applied peripheral nerve 
strain activates mTOR-mediated signaling pathways within axons, resulting in increased 
local synthesis of cytoskeletal proteins within the nerve.  Our data reveal that mTOR-
associated pathways are activated and cytoskeletal proteins increase their expression 
upon rat sciatic nerve strain. However, mTOR differentially regulates the synthesis of 
individual cytoskeletal proteins. 
Section 2: Methods 
Subsection 1: Animal care 
Animal usage was in accordance with protocols approved by the UCSD 
Institutional Animal Care and Use Committee (IACUC). For in vivo experiments, adult 
male rats between the ages of 10 – 13 weeks were utilized. For in vitro experiments, 
pregnant female rats were euthanized to obtain embryos for primary DRG culture. All 
adult animals were sacrificed by asphyxiation with CO2 followed by confirmation via 





Subsection 2: Animal surgery and nerve strain 
Anesthesia was induced with 5% isoflurane, and maintained for the duration of 
the experiments at 1.5– 3% isoflurane. The strained experimental limb was randomly 
assigned and contralateral limb was used for paired comparison. Surgery consisted of 
sciatic nerve exposure through separation of the fascial band of the biceps femoris. The 
nerve was then freed from the tissue bed by removing superficial fascia. A custom wedge 
(Figure 5-1B) was placed beneath the sciatic nerve, creating strain by elevating the nerve 
from the tissue bed (cf. bow-stringing in single axon studies [176]). This method avoided 
potential damage associated with grasping or clamping strategies for nerve lengthening. It 
also avoided regional variability in strain incurred by manipulating joint positions. 
Nerves were strained for a period of either 15 minutes (acute signaling) or 6 hours 
(protein synthesis) depending upon the desired outcome measurement. The strained 
section of the sciatic nerve was excised and flash frozen in liquid nitrogen-cooled 
isopentane, and stored at –80°C for future processing. Sham surgeries were performed on 
contralateral limbs, exposing and freeing the sciatic nerve without wedge insertion. 
Subsection 3: Rapamycin treatment 
To inhibit mTOR activity, rats were injected with 5 mg/kg rapamycin (J62473; 
Alfa Aesar) in a solution consisting of 1 mg/ml rapamycin, 5% v/v ethanol, 4% v/v 
Tween 80, 4% v/v polyethylene glycol in sterile water (as described in [177]). Carrier 
control rats were injected with the same solution without rapamycin. 
Subsection 4: Tissue homogenization and sample preparation 
Individual nerves were homogenized in 150 μl of homogenization buffer 
consisting of 20 mM Tris-HCL, 150 mM NaCL, 1% v/v NP-40, 20 mM NaF, 2 mM 
EDTA, 2.5 mM NaPP, 20 mM β-glycerophosphate and 10% glycerol [178,179]. 
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Homogenization buffer was supplemented with cOmplete (04693116001; Roche) and 
phosSTOP (04906845001; Roche) to inhibit protein degradation and dephosphorylation. 
Whole protein levels were quantified by BCA analysis. Samples were diluted to 1 μg /μl 
total protein with additional homogenization buffer, and supplemented with Laemmli 
sample buffer at 3:1 (sample:LSB). Samples were boiled at 100°C for 10 minutes to 
denature proteins prior to storage at –80°C. 
 
Figure 5-1: Experimental set-up and electrophysiology 
(A) Sciatic nerves were marked and imaged following exposure for baseline reference. 
(B) Insertion of custom wedge strained the nerve locally while minimizing damage. 
Markings were used to ensure consistent strain of the nerves. (C) Sample EMG recording 
from the TA displays characteristic depolarization and hyperpolarization following 
sciatic nerve stimulation. (D) Latency measurements made from stimulation to minimum 
and maximums of the recording trace revealed no difference following stretch compared 





Subsection 5: Western blotting  
Samples were removed from –80°C and heated at 60°C for 6 minutes. Samples 
were loaded into precast 3-8% Tris-acetate gels with 20 μg total protein per well. Gels 
were run in Tricene running buffer for 95 minutes with a constant voltage of 110 Volts. 
Following electrophoresis, proteins were transferred from the gel to a nitrocellulose 
membrane. Transfer occurred at 4°C and 200 mA for 2 hours in transfer buffer (18 g 
glycin, 3.8 g Tris base in 1 L H2O supplemented with 200 ml of methanol). The 
membrane was then blocked in 5% milk in TBS-T (2.43 g Tris base, 8 g NaCl, 0.5 μl in 
1L H2O; pH = 7.5) for 1 hour. Membrane was washed 4x (10 min, 10 min, 5 min, 5 min) 
after blocking and then placed in primary antibody in TBS-T overnight at 4°C on a 
rocker. Primary antibody was removed and membrane was again washed 4x (10 min, 10 
min, 5 min, 5 min) and secondary was added (1:1000 in TBS-T) for 1 hour. Secondary 
antibody was removed and the membrane was again washed 4x (10 min, 10 min, 5 min, 5 
min). Proteins were visualized using ECL. Blots were stripped and reprobed for 
additional proteins. Image capture and quantification of western blots was performed 
using ImageLab software. Phosphorylated levels of proteins were normalized to the total 
levels of the particular protein. To avoid confounding effects of anticipated fluctuations 
in levels of cytoskeletal proteins, which are often used for normalization, we normalized 
total protein levels to those of GAPDH (Ning 2010). Antibodies used were: pmTOR
Ser2448
 
(5536P; Cell Signaling), total mTOR (2983P; Cell Signaling), pFAK
Y397 
(44624G; Life 
Technologies), total FAK (05537; Millipore), pS6
Ser240/244
 (2215S; Cell Signaling), total 
S6 (2317S; Cell Signaling), β-actin (A5060; Sigma-Aldrich), tubulin (T9026; Sigma-
80 
 
Aldrich), SMI-31 (ab24573; abcam), GAPDH, p-p38 MAPK
T180/Y182
 (9211S; Cell 
Signaling), total p38 MAPK (9212; Cell Signaling).  
Subsection 6: Electrophysiology 
Methods were similar to [180], excepting the use of the TA rather than interosseus 
muscles to record muscle response to nerve stimulation. Briefly, following sciatic nerve 
exposure, a miniature bipolar nerve hook electrode (501650; Harvard Apparatus) was 
positioned proximal to the strained region. The tibialis anterior was exposed and needle 
recording electrodes (Grass F-E2) were positioned adjacent to the endplate zone [181]. A 
ground needle electrode was placed in the contralateral limb. Single pulses of 7 V were 
used to excite the nerve and elicit a response. At each time point, five consecutive 
recordings were made to ensure consistency of stimulation and recording, and averaged 
together to determine the latency between stimulus and recording. Unstrained 
measurements were made with the nerve in a neutral configuration, with knee and ankle 
neutral. As acute strain could not be measured with the wedge in place, for these 
measurements, strain was applied by elevation of the nerve cuff to match the degree of 
strain applied via wedge implantation. Wedges were used to impose strain during the 360 
minute period. Measurements were made at the following time points in the following 
order: unstrained T=0 min, strained T=0 min, strained T = 15 min, unstrained 15 min, 
strained 360 min, unstrained 360 min, unstrained 375 min (an additional 15 min rest 
period following wedge removal).  
Subsection 7: Statistics 
Paired t-tests were used to compare contralateral strained versus unstrained nerves 
(Excel; Microsoft). We used R to run two-way ANOVAs to compare the effects of both 
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rapamycin treatment and strain for signaling characterization. Experimental groups of 8 
rats were used for all experiments except where otherwise noted. 
Section 3: Results 
Subsection 1: Validation of strategy for in vivo nerve strain 
We developed methodology to strain rat sciatic nerves without incurring damage 
associated with clamping or grasping the nerve. Insertion of a custom-made isosceles 
trapezoidal wedge into the underlying nerve bed imparted a consistent tensile strain on 
the top edge of the wedge by bow-stringing the nerve. Rounded corners of the wedge 
minimized any nerve tethering, and allowed a gradual reduction of strain along regions of 
the nerve descending from the wedge. Nerves were subjected to calculated strains of 
11.24 ± 0.95% (Mean ± SEM, n = 5), within the upper limits of physiological strains 
[54]. 
To confirm that nerves did not experience injurious compression or damage over 
the course of the experiment, conduction latencies to the TA were measured, following 
stimulation of the sciatic nerve proximal to the site of strain (Figure 5-1C). Comparison 
of pre-stretch latencies with those following 360 minutes showed no significant 
differences in both the latencies to primary and secondary peaks (Figure 5-1D, Table 5-
1). Additionally, while signal amplitude was variable from time point to time point 
(though not for repeated measurements within a time point), at no point did we see a 
significant reduction in amplitude to peak amplitude between pre-stretch (4.26 ± 2.22 V), 
5 hours stretch (7.09 ± 1.40 V), and recovered (6.49 ± 1.38 V). The apparent increase in 
amplitude is likely a result of increased recruitment of fibers by the electrode due to 




Table 5-1: TA EMG latencies 
Latency values from TA EMG recordings following sciatic nerve stimulation (Mean ± 
SEM, n = 3). No significant difference, paired t-test to pre-stretch (all p > 0.05) 
 
Subsection 2: mTOR pathway activation and cytoskeletal protein expression 
following nerve strain 
To determine if mTOR-associated translational pathways were activated in 
strained nerves, away from neuronal cell bodies, we first used Western blot analysis to 
examine the response of FAK and mTOR activation levels following 15 minutes of 
applied strain. Consistent with other model systems, a trend towards rapid mTOR 
activation with strain was observed by a 40% increase in the p-mTOR/mTOR ratio for 
strained nerves compared to unstrained (p = 0.070, paired t-test; Figures 5-2A-B). 
Interestingly, however, FAK signaling was unresponsive at this early time point 
suggesting an alternate mode of initiation (Figures 5-2A-B). Following 6 hours of applied 
strain, mTOR signaling persisted, with an increase of 37% over unstrained nerves (p = 
0.002, paired t-test; Figures 5-2C-D). Consistent with this activity, we also observed a 
28% increase in activation of S6, a translational regulator downstream of mTOR, at 6 
hours, in strained compared to unstrained nerves (p = 0.014, paired t-test; Figures 5-2C-
D).  
We then tested whether strain induced a correlative increase in cytoskeletal 
expression. We focused on expression of β-actin, neurofilament heavy subunit (NFH) and 




Figure 5-2 Strain induced signaling and protein expression 
(A) Application of strain for 15 minutes revealed a trend towards increased mTOR 
phosphorylation with constant levels of FAK signaling (n = 4) as revealed by western 
blotting (B). (C) Following 6 hours of strain application, a significant increase was 
observed in both mTOR and S6 phosphorylation levels following the application of strain 
as revealed by western blotting (D). (E) β-actin and SMI31 levels significantly increased 
following application of strain while tubulin and total mTOR levels remained constant 




Cytoskeletal protein levels were normalized to GAPDH, a non-cytoskeletal marker. 
Following 6 hours of strain, relative to unstrained contralateral nerves, we observed 
increases in both β-actin (130%; p = 0.035, paired t-test; Figures 5-2E-F) and SMI-31 
(67%; p = 0.008, paired t-test; Figures 5-2E-F). Tubulin, on the other hand, failed to 
show any change in levels following strain application (p= 0.446, paired t-test; Figures 5-
2E-F).  
Subsection 3: Rapamycin differentially regulates strain induced cytoskeletal 
protein synthesis 
Given the correlation between increased mTOR and S6 activation and increases in 
cytoskeletal protein levels following 6 hours of strain, we next tested the hypothesis that 
inhibition of mTOR complex 1 (the mTOR complex associated with activation of S6) via 
systemic rapamycin administration would suppress these increases. Rapamycin was 
administered 1 hour prior to the 6 hour period of strain application. To confirm 
rapamycin activity we examined the level of mTOR activation following strain 
application by western blot. Both the contralateral, unstrained nerve (50% reduction; 
Figures 5-3A-B) and strained nerves (30% reduction; Figures 5-3A-B) revealed a 
significant reduction in mTOR activation. Two-way ANOVA analysis for strain and 
rapamycin revealed a significant rapamycin dependent decrease in mTOR activation (p = 
6.86x10
-13
). Additionally, a strain effect (p = 1.18x10
-6
) and slight interaction effect (p = 
0.074) were observed, suggesting that mTOR activation may be disproportionately 
suppressed in strained nerves. Consistent with these data, similar analysis of activated S6 




Figure 5-3: Effect of rapamycin on strain induced signaling and protein expression 
Application of mTOR led to a reduction in phosphorylated levels of both mTOR (A, B) 
and S6 (C, D). The effect of strain remains following rapamycin administration but was 
muted at the level of S6. Administration of rapamycin prior to strain differentially 
regulated protein levels (E, F): β-actin remained elevated, SMI31 was suppressed to 
baseline, and both tubulin and total mTOR were reduced beyond baseline (*p < 0.05, 
paired t-test; two-way ANOVA, Strain: ^p < 0.05, Rapamycin: 
+




limb (82% reduction; Figures 5-3C-D) and the strained nerve (85% reduction; Figures 5-
3C-D). Two-way ANOVA analysis for strain and rapamycin also revealed a significant 
decrease in S6 levels following rapamycin administration (p = 8.89x10
-12
). In this case 
there was no strain effect (p = 0.15) but a slight interaction effect (p = 0.0841). Post hoc 
comparison of individual groups revealed a significant effect of strain in the absence of 
rapamycin which disappears following rapamycin administration (No Rapamycin, p = 
0.014; Rapamycin, p = 0.632). 
Interestingly, rapamycin treatment revealed differential translational regulation of 
the three probed cytoskeletal proteins. β-actin expression remained elevated following 
strain application (p = 0.027; Figures 5-3E-F). However, PNF returned to levels nearly 
equal to those of the unstrained nerve (p = 0.58; Figures 5-3E-F), while tubulin saw a 
significant decrease relative to the unstrained nerve (61% reduction; p = 0.002). These 
results suggest differential activation of mTOR associated pathways at the expense of 
baseline maintenance pathways. 
Subsection 4: Alternative protein synthesis pathways are activated in response to 
strain application 
In light of the differential regulation of mTOR, and the possibility that other 
translational pathways are also at work, p38 activation was probed. There was no effect 
of strain or rapamycin treatment (Strain: p = 0.918, Rapamycin: p = 0.123, Interaction: p 
= 0.123, two-way ANOVA). However, in the absence of rapamycin, there was an almost 
70% reduction in p38 activation levels following the application of strain (p = 0.075; 
Figures 5-4A-B). Interestingly, though, in the presence of rapamycin, there was a trend 
towards increased levels following strain application in the rapamycin group (p = 0.430; 
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Figures 5-4A-B), suggesting complex interactions between mTOR signaling, p38 
signaling, and strain.  
 
Figure 5-4: p38 MAPK signaling response to strain 
Application of mTOR led to a reduction in phosphorylated levels of both mTOR (A, B) 
and S6 (C, D) (graphs normalized to unstrained, no rapamycin group). The effect of 
strain remains following rapamycin administration but was muted at the level of S6. 
Administration of rapamycin prior to strain differentially regulated protein levels (E, F) 
(protein data normalized to unstrained, rapamycin treated): β-actin remained elevated, 
SMI31 was suppressed to baseline, and both tubulin and total mTOR were reduced 
beyond baseline (*p < 0.05, paired t-test; two-way ANOVA, Strain: ^p < 0.05, 
Rapamycin: 
†
p < 0.05); Mean ± SEM 
 
Section 4: Discussion 
In this study, we implemented a novel experimental model to examine 
translational pathways in response to nerve strain, in the absence of nerve injury. Our 
results suggest that strain induces increased cytoskeletal expression in sciatic nerves. This 
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increase in expression is at least partially coupled to activation of mTOR pathways for 
neurofilaments and tubulin, but not β-actin.  
Although not a prototypical load-bearing tissue, nerves experience, accommodate, 
and respond to tensile deformations [54,56]. At the tissue level, such loading is well-
described during joint movement, limb lengthening surgery [54,71], and more recently, 
strategies for end-to-end nerve repair [78] and strain-based regenerative strategies 
[21,182]. In single neurons, moderate strains induce beneficial outcomes [75-77], with 
one study reporting a dramatic ~eight-fold increase in axonal elongation rates [75].  
In vivo, axons themselves may, at least partially, be protected from nerve strain 
by their unique undulating packing architecture within the nerves as well as properties of 
the extracellular matrix [3,56,57]. However, when axons themselves are strained, whether 
in vivo or in vitro, details on how they respond to deformation are poorly understood. An 
important observation was that axons do not display reduced caliber with strain, 
indicating volumetric expansion as well as structural stability [173]. Multiple sources of 
material may contribute to this expansion. In the short-term, pre-existing pools of 
material may be rapidly recruited from flanking regions of the cell body, consistent with 
the anterograde cytoskeletal flow posited during axonal outgrowth [41,173]. To 
accommodate long-term volume expansion additional material must be newly 
synthesized, either in the cell body or, as we hypothesize, locally within the axon. 
Though not evaluated until this study in the context of neuronal strain, the mTOR 
pathway was hypothesized to be a strong candidate for modulating strain-induced local 
protein synthesis. This pathway is known to respond to loading in muscles by enhancing 
protein synthesis and leading to hypertrophy [79]. Additionally, in neurons it is known to 
89 
 
be vitally important in axonal elongation and regeneration following nerve injury 
[70,81,82], as well as for local protein synthesis, which is central to both of these 
processes [69]. In support of this hypothesis, we observed that strain induced a rapid and 
persistent increase in mTOR activation as well as downstream activation of S6 (Figures 
5-2A-B).  
While any number of proteins may be regulated through mTOR-S6 pathways, we 
focused on cytoskeletal proteins, whose synthesis is essential to volume expansion [183-
185]. Expression of each of the three cytoskeletal elements that we examined, β-actin, 
neurofilament-H, and tubulin, appeared to be differentially induced by stretch. As 
observed following nerve injury, β-actin levels also increased following nerve strain. 
Similarly, phosphorylated neurofilament levels also increased. On the other hand, tubulin 
levels remained relatively unchanged with strain.  
Intriguingly, regulation of cytoskeletal protein translation was also differentially 
regulated. Rapamycin treatment induced an approximately 50% reduction in activated 
mTOR levels and an over 80% reduction in activated S6 levels across experimental 
groups. Following reduction of mTOR activation, β-actin levels remained elevated but 
the response of both PNF and tubulin were altered. PNF levels were reduced in the 
strained configuration, leading to no difference in protein levels relative to the unstrained 
configuration. A reduction in tubulin levels in response to strain was also observed. It is 
thus likely that mTOR signaling is responsible for the observed increase in PNF 
following strain application, as well as some component of maintenance of tubulin levels. 
The maintained increase in β-actin levels suggests that an alternative signaling pathway is 
responsible for either de novo synthesis of β-actin or local recruitment to the region of 
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strain. This prompted our investigation of the p38 MAPK/eIF2 pathway as an alternate 
regulatory mechanism for β-actin levels following rapamycin treatment. We observed 
opposing trends in strain activation of p38 MAPK, depending on the presence of 
rapamycin, suggesting the potential for interaction between the two pathways in 
responding to strain. An alternate possibility is translational regulation of β-actin via 
RNA binding proteins. A likely candidate for such regulation is the β-actin binding 
protein zipcode binding protein 1 (ZBP1), whose activity appears to be controlled by 
calcium-mediated Src pathways [186,187]. While manipulation of these non-mTOR 
pathways is necessary to conclude a formal role, our results leave open the compelling 
possibility of competing or synergistic translational regulatory pathways.  
While decreased PNF and tubulin levels in nerves following mTOR inhibition 
points to a strong likelihood for local synthesis, we cannot exclude contributions from 
other sources for the cytoskeletal protein increases. Both the cell body and flanking 
regions may potentially provide material for axonal growth and response to strain, 
however at our six hour time point this contribution is likely to be negligible. Transport 
of cytoskeletal cargoes is well characterized as slow component transport, with bulk rates 
of β-actin, tubulin, and neurofilaments transport rarely exceeding mm/day [59,60]. At 
these rates, six hours is likely an insufficient amount of time for newly transported 
proteins to appreciably contribute to measured increases, which were on the order of 
50%.  
While we cannot exclude contributions from other cellular populations in the in 
vivo response, SMI-31 is almost exclusively neuronal and likely represents a specifically 
neuronal response.  
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Section 5: Conclusions 
Application of excessive strain and tension on nerves has a major deleterious 
effect which at the greatest extremes fully eliminates a nerve’s conductive capacity while 
under experimental load [55,56]. At the extremes only minimal recovery of the signal is 
seen following relaxation [55,56]. In our study we were able to minimize damage as 
evidenced by our electrophysiological results. Nonetheless, application of moderate strain 
led to enhancement of mTOR signaling and cytoskeletal protein levels. The enhancement 
of cytoskeletal protein levels responded differentially to the inhibition of mTOR via 
rapamycin suggesting differential regulation of the local synthesis response to strain. Our 
work is among the first to identify a partial mechanism for the nerve’s ability to respond 
and adapt to strain. It also provides the first evidence that developmental pathways may 
be, at least in part, recapitulated in a non-injury situation.  
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Chapter 6: Conclusions 
Section 1: Introduction 
Peripheral nervous system (PNS) injury affects many people every year. If 
function cannot be fully restored results in a number of burdens ranging from reduced or 
complete loss of motor and sensory function [8]. Current regenerative techniques are 
sufficient in a number of cases but best expected outcomes still result from grafting of 
donor tissues which are coupled with a number of complications ranging from donor site 
morbidity to host rejection [188,189]. For these reasons a number of alternative 
regenerative strategies including grafting of Schwann cells to application of strain are 
being explored in the hope of enhancing restoration of primary function to individuals 
[5]. While, both Schwann cells and strain have been noted to provide enhancements in 
the regenerative capacity of neurons both in vitro and in vivo [20,75-77,190], the 
mechanisms by which these two methods are able to achieve this are still poorly 
understood. My work, formatted in the framework of a two-arm study, examined 
mechanisms underlying both Schwann cell-neuron interactions as well as the response of 
nerves to the application of strain in the context of future applications to PNS 
regeneration techniques. 
Arm 1: I investigated the interaction of Schwann cells and neurons in the context 
of membrane stability (Chapter 2) and transport and localization of ribosomes in 
Schwann cells during early myelination (Chapter 3).  
Arm 2: I investigated both the physical (Chapter 4) and molecular signaling 




Section 2: Implications of my work 
 My work in the broadest sense has begun to open the doors for future studies with 
direct translational applications for peripheral nerve repair. In a narrower sense, each 
chapter advances the field’s understanding of how neurons and nerves respond to their 
environment in a particular context. My work achieved this by enhancing the 
understanding of how neurons and Schwann cells interact and affect each other (Chapters 
2 and 3) and how nerves respond to strain application (Chapters 4 and 5) with the specific 
details of each chapter found in the subsequent subsections. 
Subsection 1: Variability in membrane continuity between Schwann cells and 
neurons [2] 
In Chapter 2, I investigated the differences between the membrane stability of 
Schwann cells and neurons and how interactions between the two cell types can affect the 
stability.  I found inherent differences between the membrane stability of Schwann cells 
and neurons. This difference manifested itself through changes in both membrane 
velocity and membrane correlation. The more mobile Schwann cells exhibited both 
higher membrane velocity and more correlated movement of membrane patches. We 
posited that these differences may result from the underlying cytoskeletal structure and 
developmental demands of each cell type.  
Interesting trends were observed based upon the contact state of the cells. In this 
case when Schwann cells were contacting neurons and vice versa there were trends 
towards decreases in both membrane velocity and membrane correlation. The velocity 
decreases point towards a more stable cellular state. Further support for this idea of 
cellular stability emerged from the identification of a trend towards increased levels of 
cell-cell or cell-substrate contact inferred from increased levels of talin immunostaining 
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in Schwann cells upon development of contact with neurons. This is in agreement with 
previous observations of Schwann cells’ ability to upregulate adhesion following 
neuronal contact [34]. Additionally Schwann cells are capable of increasing 
neurofilament phosphorylation levels [35] a hallmark of mature axons [191-193]. It is 
perhaps through increased neurofilament phosphorylation that the trend towards stable 
neuronal membrane was established in my study. Extrapolating from what I have found, 
scientists that intend to incorporate Schwann cells into their regenerative strategy may 
wish to explicitly consider their delivery method. Introduction of Schwann cells via 
engraftment within the conduit or injection at the site of repair could have vastly different 
effects on the physical stability of the cells and the regeneration process. 
Subsection 2: Ribosomal trafficking in Schwann cells depends on early 
myelination cues 
 Inspired by the work detailing the transfer of ribosomes from Schwann cells to 
neurons following axonal injury [27,28] I investigated the development and maintenance 
of these populations in an in vitro culture model of the initial stages of myelination in 
Chapter 3. I found that Schwann cells initially develop distributions of stable ribosome 
clusters along the length of their projections within the first day of plating. These 
distributions are well conserved throughout the early development of the Schwann cell 
and following initiation of myelination. Interestingly the level of ribosomal transport 
decreased over time with the induction of myelination. In the absence of myelination 
induction, the level of ribosomal transport actually increased.  
 While others have noted ribosomes in the myelinated fraction of Schwann cells, it 
has only been within the context of MBP production [48-52]. Additionally, their notable 
localization near Schmidt-Lanterman incisures [48] leaves open the possibility for their 
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transfer following axonal injury [27]. Prior to myelination ribosomes localized to 
Schwann cell projections may possess larger responsibilities including focal adhesion and 
cytoskeletal turnover, important processes in the development and migration of 
unmyelinated Schwann cells. Building off my work, an effort to enhance the ribosomal 
presence within the myelin compartment of Schwann cells may be used to provide an 
enhanced source of ribosomes for local protein synthesis following injury. While 
ribosomal densities are observed early and maintained throughout our experimental time 
frame, enhanced levels could perhaps be reached by manipulation of the transport 
pathways following myelination may allow scientists to  
Subsection 3: Nerve strain correlates with structural changes quantified by Fourier 
analysis [3] 
 Bands of Fontana are an observable banding pattern on the surface of nerves 
[163] which is well conserved across species and nerves types [166]. Implementing 
pattern detection methods previously used in other tissues [170] I was able to identify 
correlations between applied strains and the banding frequency in Chapter 4. These 
findings complement the work in Chapter 5 that investigated the effect of strain on local 
protein synthesis and signaling. If future surgical interventions integrate strain into a 
regenerative strategy or monitor strain during other nerve manipulations, it will be 
important that they impart moderate levels of strain below the damage threshold. 
Development of a tool using the relationship noted here between strain and banding 
pattern can allow surgeons to make simple, accurate, real-time measurements of strain 





Subsection 4: Differential regulation of cytoskeletal protein synthesis following 
nerve strain 
 In Chapter 5 I identified strain dependent changes in cytoskeletal levels and 
protein synthetic signaling pathways. I found increases in cytoskeletal proteins β-actin 
and phosphorylated neurofilament-H (SMI31). A strain dependent increase in the protein 
signaling pathway driven by mTOR activation via was observed through increases in 
mTOR signaling and downstream S6 phosphorylation. With the application of the mTOR 
inhibitor rapamycin I found differential regulation of the various cytoskeletal elements in 
response to strain. The increase in β-actin remained whereas the increase in SMI31 was 
eliminated. Additionally, I found a strain dependent decrease in both tubulin and total 
mTOR following inhibition of mTOR with rapamycin.  
 Strain as a positive regulator of axonal outgrowth has begun to be explored in 
vitro [75-77]. In culture, rates of axonal elongation far exceeding native rates have been 
witnessed [75]. The processes underlying the strain-dependent enhancement of outgrowth 
are not yet understood. Combining the current understanding of the fields of muscle 
mechanics [79,80] and axonal elongation [69,70,81,82] I hypothesized that the 
application of strain will enhance activation of mTOR signaling within the axon leading 
to the production of cytoskeletal proteins to aid the growing axon.  The finding that 
nerves increase activation of mTOR and downstream signals within the protein synthesis 
pathway locally supports our hypothesis. The adaptation of the nerve to increase levels of 
cytoskeletal proteins in response to strain provides a potential material and framework for 
axonal elongation. Complete understanding of the strain response of nerves is necessary 
before translational applications of this strategy can be effectively integrated into the 
operating room. Additionally, investigation into the complementation of a strain-based 
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strategy with other regenerative strategies including growth factor incorporation [16] and 
Schwann cell supplementation [20] will help to define the upper limits of regeneration 
attainable by this method. 
Section 3: Future experiments and translational impact 
My work has set the stage for a number of future studies to fully elucidate the 
context of the work within the context of translational surgical applications. In the 
immediate future a complementary in vitro study to Chapter 5 must be completed to fully 
characterize the role of strain in activation of neuronal local protein synthesis. 
Subsection 1: Future experiments 
 Prior to peer-reviewed publication of Chapter 5, a complementary study 
investigating the application of strain on neurons in vitro and their response must be 
completed. The results in whole nerve provide significant evidence that neurons are 
actively responding to the applied strain. Specifically the increase in SMI31, an axonally 
specific protein, supports the idea that the neurons themselves are responding to the 
application of strain. Nonetheless, an in vitro model will do well to support our results in 
the context of neuronally specific activation.  
 Two methods have been devised to complete this task. First, puromycin 
incorporation as a surrogate for protein synthesis [194] will be utilized to identify the 
levels of proteins synthesized in a one hour time window within the axonal compartment 
of dissociated DRGs grown on a flexible substrate. Immunoflourescence quantification of 
puromycin levels (Figure 6-1) similar to talin identification (Figure 2-5) in Chapter 2 will 
be used to quantify and compare synthesis rates in strained and unstrained neurons. As 
this method reveals non-specific protein synthesis, an alternative method may be utilized. 
Whole adult DRGs will be plated and grown for three days on flexible substrates with 
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experimental wells subjected to a period of six hours of strain on Day 3. Following strain 
administration axons in the direction of strain will be collected and processed for western 
blots as done in Chapter 5. Identification of axonally specific changes in signaling and 
protein levels will allow us to strengthen our in vivo results. 
 
Figure 6-1: Immunolabeling of puromycin incorporation 
Identification of puromycin incorporation within cultured DRGs can provide details 
about the amounts and localization of newly synthesized proteins 
 
Subsection 2: Translational impact 
 While the work I have done presents little direct translational impact, it manages 
to open the door for a number of future studies to expand on, clarify, and incorporate my 
work into translational therapies. The work in Chapters 2 and 3 provides an important 
understanding of how Schwann cells and neurons interact with each other in the context 
of membrane stability and ribosomal incorporation in the myelin fraction. These two 
results point to the importance of interactions that should be considered prior to the 
incorporation of Schwann cells in a regenerative solution. Specific considerations include 
the manipulation of the Schwann cells prior to implantation and the method of 
introduction either through incorporation on a guidance conduit or direct injection. 
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 Chapter 4 offers a unique technique that can be incorporated in surgical settings. 
Current surgical convention is to perform tension-free nerve repairs in light of growing. 
Even within current convention, being able to accurately identify the lower limits of 
strain application can limit the size of the surgical gap and potentially improve expected 
outcomes. 
 Chapter 5 focuses on the role strain application has on inducing local protein 
synthesis within the whole nerve. My study was performed outside of the context of 
injury but could potentially be applied to regenerative techniques. Validation of my 
results in the context of recovery following injury will go a long way towards garnering 
support for translational application of this technique in a regeneration strategy. With the 
well-documented importance of local protein synthesis in axonal regeneration and 
elongation [69,81] identification of a local protein synthesis response to strain further 
validates it as a promising repair component. Further understanding of the strain response 
might allow incorporation of the underlying signaling response without the physical 
limitations of strain application and consideration of the inevitable associated pain. 
 The work presented here provides context for a number of peripheral nervous 
system regeneration strategies, offers additional considerations for the future 
development of translational therapeutics, and proposes mechanisms by which the 
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